BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schattenberg JM, Singh R, Wang Y, Lefkowitch JH, Rigoli RM, Scherer PE, Czaja MJ. JNK1 but not JNK2 promotes the development of steatohepatitis in mice. Hepatology. 2006;43:163-172. [PMID: 16374858 DOI: 10.1002/hep.20999] [Cited by in Crossref: 289] [Cited by in F6Publishing: 284] [Article Influence: 18.1] [Reference Citation Analysis]
Number Citing Articles
1 Starley BQ, Calcagno CJ, Harrison SA. Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection. Hepatology 2010;51:1820-32. [DOI: 10.1002/hep.23594] [Cited by in Crossref: 871] [Cited by in F6Publishing: 819] [Article Influence: 72.6] [Reference Citation Analysis]
2 Pierce AA, Pickens MK, Siao K, Grenert JP, Maher JJ. Differential hepatotoxicity of dietary and DNL-derived palmitate in the methionine-choline-deficient model of steatohepatitis. BMC Gastroenterol 2015;15:72. [PMID: 26103964 DOI: 10.1186/s12876-015-0298-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
3 Gehrke N, Garcia-Bardon D, Mann A, Schad A, Alt Y, Wörns MA, Sprinzl MF, Zimmermann T, Menke J, Engstler AJ, Bergheim I, He YW, Galle PR, Schuchmann M, Schattenberg JM. Acute organ failure following the loss of anti-apoptotic cellular FLICE-inhibitory protein involves activation of innate immune receptors. Cell Death Differ 2015;22:826-37. [PMID: 25342470 DOI: 10.1038/cdd.2014.178] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
4 Singh R, Wang Y, Xiang Y, Tanaka KE, Gaarde WA, Czaja MJ. Differential effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance. Hepatology. 2009;49:87-96. [PMID: 19053047 DOI: 10.1002/hep.22578] [Cited by in Crossref: 159] [Cited by in F6Publishing: 158] [Article Influence: 12.2] [Reference Citation Analysis]
5 Han CW, Kang ES, Ham SA, Woo HJ, Lee JH, Seo HG. Antioxidative effects of Alisma orientale extract in palmitate-induced cellular injury. Pharm Biol. 2012;50:1281-1288. [PMID: 22857151 DOI: 10.3109/13880209.2012.673629] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
6 Gan LT, Van Rooyen DM, Koina ME, McCuskey RS, Teoh NC, Farrell GC. Hepatocyte free cholesterol lipotoxicity results from JNK1-mediated mitochondrial injury and is HMGB1 and TLR4-dependent. J Hepatol. 2014;61:1376-1384. [PMID: 25064435 DOI: 10.1016/j.jhep.2014.07.024] [Cited by in Crossref: 93] [Cited by in F6Publishing: 89] [Article Influence: 11.6] [Reference Citation Analysis]
7 Larter CZ, Yeh MM, Van Rooyen DM, Brooling J, Ghatora K, Farrell GC. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis. J Gastroenterol Hepatol. 2012;27:341-350. [PMID: 21929649 DOI: 10.1111/j.1440-1746.2011.06939.x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 60] [Article Influence: 6.0] [Reference Citation Analysis]
8 Lloyd CM, Phillips AR, Cooper GJ, Dunbar PR. Three-colour fluorescence immunohistochemistry reveals the diversity of cells staining for macrophage markers in murine spleen and liver. Journal of Immunological Methods 2008;334:70-81. [DOI: 10.1016/j.jim.2008.02.005] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 3.8] [Reference Citation Analysis]
9 Manco M, Putignani L, Bottazzo GF. Gut Microbiota, Lipopolysaccharides, and Innate Immunity in the Pathogenesis of Obesity and Cardiovascular Risk. Endocrine Reviews 2010;31:817-44. [DOI: 10.1210/er.2009-0030] [Cited by in Crossref: 268] [Cited by in F6Publishing: 262] [Article Influence: 22.3] [Reference Citation Analysis]
10 Seki E, Brenner DA, Karin M. A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches. Gastroenterology. 2012;143:307-320. [PMID: 22705006 DOI: 10.1053/j.gastro.2012.06.004] [Cited by in Crossref: 304] [Cited by in F6Publishing: 298] [Article Influence: 30.4] [Reference Citation Analysis]
11 Buzzetti E, Pinzani M, Tsochatzis EA. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism 2016;65:1038-48. [DOI: 10.1016/j.metabol.2015.12.012] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Soon RK, Yan JS, Grenert JP, Maher JJ. Stress signaling in the methionine-choline-deficient model of murine fatty liver disease. Gastroenterology. 2010;139:1730-1739, 1739.e1. [PMID: 20682321 DOI: 10.1053/j.gastro.2010.07.046] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 3.0] [Reference Citation Analysis]
13 Syn WK, Choi SS, Diehl AM. Apoptosis and cytokines in non-alcoholic steatohepatitis. Clin Liver Dis 2009;13:565-80. [PMID: 19818305 DOI: 10.1016/j.cld.2009.07.003] [Cited by in Crossref: 77] [Cited by in F6Publishing: 80] [Article Influence: 5.9] [Reference Citation Analysis]
14 Pickens MK, Yan JS, Ng RK, Ogata H, Grenert JP, Beysen C, Turner SM, Maher JJ. Dietary sucrose is essential to the development of liver injury in the methionine-choline-deficient model of steatohepatitis. J Lipid Res. 2009;50:2072-2082. [PMID: 19295183 DOI: 10.1194/jlr.m900022-jlr200] [Cited by in Crossref: 69] [Cited by in F6Publishing: 41] [Article Influence: 5.3] [Reference Citation Analysis]
15 Bogoyevitch MA. The isoform-specific functions of the c-Jun N-terminal Kinases (JNKs): differences revealed by gene targeting. Bioessays 2006;28:923-34. [PMID: 16937364 DOI: 10.1002/bies.20458] [Cited by in Crossref: 134] [Cited by in F6Publishing: 130] [Article Influence: 8.9] [Reference Citation Analysis]
16 Xu J, Lai KKY, Verlinsky A, Lugea A, French SW, Cooper MP, Ji C, Tsukamoto H. Synergistic steatohepatitis by moderate obesity and alcohol in mice despite increased adiponectin and p-AMPK. J Hepatol. 2011;55:673-682. [PMID: 21256905 DOI: 10.1016/j.jhep.2010.12.034] [Cited by in Crossref: 94] [Cited by in F6Publishing: 91] [Article Influence: 8.5] [Reference Citation Analysis]
17 Jian T, Wu Y, Ding X, Lv H, Ma L, Zuo Y, Ren B, Zhao L, Tong B, Chen J, Li W. A novel sesquiterpene glycoside from Loquat leaf alleviates oleic acid-induced steatosis and oxidative stress in HepG2 cells. Biomed Pharmacother 2018;97:1125-30. [PMID: 29136950 DOI: 10.1016/j.biopha.2017.11.043] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
18 Yoo NY, Jeon S, Nam Y, Park YJ, Won SB, Kwon YH. Dietary Supplementation of Genistein Alleviates Liver Inflammation and Fibrosis Mediated by a Methionine-Choline-Deficient Diet in db/db Mice. J Agric Food Chem 2015;63:4305-11. [PMID: 25885479 DOI: 10.1021/acs.jafc.5b00398] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.1] [Reference Citation Analysis]
19 Malhi H, Gores GJ. Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease. Semin Liver Dis. 2008;28:360-369. [PMID: 18956292 DOI: 10.1055/s-0028-1091980] [Cited by in Crossref: 346] [Cited by in F6Publishing: 339] [Article Influence: 24.7] [Reference Citation Analysis]
20 Cai Y, Xu MJ, Koritzinsky EH, Zhou Z, Wang W, Cao H, Yuen PS, Ross RA, Star RA, Liangpunsakul S, Gao B. Mitochondrial DNA-enriched microparticles promote acute-on-chronic alcoholic neutrophilia and hepatotoxicity. JCI Insight 2017;2:92634. [PMID: 28724791 DOI: 10.1172/jci.insight.92634] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 8.0] [Reference Citation Analysis]
21 Kodama Y, Kisseleva T, Iwaisako K, Miura K, Taura K, De Minicis S, Osterreicher CH, Schnabl B, Seki E, Brenner DA. c-Jun N-terminal kinase-1 from hematopoietic cells mediates progression from hepatic steatosis to steatohepatitis and fibrosis in mice. Gastroenterology. 2009;137:1467-1477.e5. [PMID: 19549522 DOI: 10.1053/j.gastro.2009.06.045] [Cited by in Crossref: 120] [Cited by in F6Publishing: 127] [Article Influence: 9.2] [Reference Citation Analysis]
22 Kosters A, White DD, Sun H, Thevananther S, Karpen SJ. Redundant roles for cJun-N-terminal kinase 1 and 2 in interleukin-1beta-mediated reduction and modification of murine hepatic nuclear retinoid X receptor alpha. J Hepatol 2009;51:898-908. [PMID: 19767119 DOI: 10.1016/j.jhep.2009.06.029] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
23 Malhi H, Barreyro FJ, Isomoto H, Bronk SF, Gores GJ. Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity. Gut 2007;56:1124-31. [PMID: 17470478 DOI: 10.1136/gut.2006.118059] [Cited by in Crossref: 160] [Cited by in F6Publishing: 150] [Article Influence: 10.7] [Reference Citation Analysis]
24 Maher JJ. New insights from rodent models of fatty liver disease. Antioxid Redox Signal 2011;15:535-50. [PMID: 21126212 DOI: 10.1089/ars.2010.3749] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 3.5] [Reference Citation Analysis]
25 Sharma M, Urano F, Jaeschke A. Cdc42 and Rac1 are major contributors to the saturated fatty acid-stimulated JNK pathway in hepatocytes. J Hepatol 2012;56:192-8. [PMID: 21703174 DOI: 10.1016/j.jhep.2011.03.019] [Cited by in Crossref: 52] [Cited by in F6Publishing: 57] [Article Influence: 4.7] [Reference Citation Analysis]
26 Rondinone CM. Kinase-dependent pathways and the development of insulin resistance in hepatocytes. Expert Rev Endocrinol Metab 2007;2:195-203. [PMID: 30754170 DOI: 10.1586/17446651.2.2.195] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
27 Hanawa N, Shinohara M, Saberi B, Gaarde WA, Han D, Kaplowitz N. Role of JNK translocation to mitochondria leading to inhibition of mitochondria bioenergetics in acetaminophen-induced liver injury. J Biol Chem. 2008;283:13565-13577. [PMID: 18337250 DOI: 10.1074/jbc.m708916200] [Cited by in Crossref: 343] [Cited by in F6Publishing: 227] [Article Influence: 24.5] [Reference Citation Analysis]
28 Lu Y, Cederbaum AI. CYP2E1 potentiation of LPS and TNFα-induced hepatotoxicity by mechanisms involving enhanced oxidative and nitrosative stress, activation of MAP kinases, and mitochondrial dysfunction. Genes Nutr. 2010;5:149-167. [PMID: 19798529 DOI: 10.1007/s12263-009-0150-5] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
29 Han MS, Park SY, Shinzawa K, Kim S, Chung KW, Lee JH, Kwon CH, Lee KW, Lee JH, Park CK, Chung WJ, Hwang JS, Yan JJ, Song DK, Tsujimoto Y, Lee MS. Lysophosphatidylcholine as a death effector in the lipoapoptosis of hepatocytes. J Lipid Res. 2008;49:84-97. [PMID: 17951222 DOI: 10.1194/jlr.m700184-jlr200] [Cited by in Crossref: 144] [Cited by in F6Publishing: 81] [Article Influence: 9.6] [Reference Citation Analysis]
30 Tan J, Gao W, Yang W, Zeng X, Wang L, Cui X. Isoform-specific functions of c-Jun N-terminal kinase 1 and 2 in lung ischemia-reperfusion injury through the c-Jun/activator protein-1 pathway. J Thorac Cardiovasc Surg 2021;162:e143-56. [PMID: 32414595 DOI: 10.1016/j.jtcvs.2020.03.083] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
31 Li H, Toth E, Cherrington NJ. Asking the Right Questions With Animal Models: Methionine- and Choline-Deficient Model in Predicting Adverse Drug Reactions in Human NASH. Toxicol Sci 2018;161:23-33. [PMID: 29145614 DOI: 10.1093/toxsci/kfx253] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
32 Ngoei K, Catimel B, Church N, Lio D, Dogovski C, Perugini M, Watt P, Cheng H, Ng D, Bogoyevitch M. Characterization of a novel JNK (c-Jun N-terminal kinase) inhibitory peptide. Biochemical Journal 2011;434:399-413. [DOI: 10.1042/bj20101244] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
33 Lee GS, Yan JS, Ng RK, Kakar S, Maher JJ. Polyunsaturated fat in the methionine-choline-deficient diet influences hepatic inflammation but not hepatocellular injury. J Lipid Res. 2007;48:1885-1896. [PMID: 17526933 DOI: 10.1194/jlr.M700181-JLR200] [Cited by in Crossref: 47] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
34 Koike K. Oxidative stress and apoptosis in hepatitis C: the core issue. J Gastroenterol 2006;41:292-4. [PMID: 16699868 DOI: 10.1007/s00535-006-1786-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
35 Liu L, Wang C, Lee C, Su S, Chen H, Hsu J, Lee H. Aqueous extract of Hibiscus sabdariffa L. decelerates acetaminophen-induced acute liver damage by reducing cell death and oxidative stress in mouse experimental models: HSE attenuation of AAP-induced acute liver damage. J Sci Food Agric 2010;90:329-37. [DOI: 10.1002/jsfa.3821] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
36 Cazanave SC, Mott JL, Elmi NA, Bronk SF, Werneburg NW, Akazawa Y, Kahraman A, Garrison SP, Zambetti GP, Charlton MR, Gores GJ. JNK1-dependent PUMA expression contributes to hepatocyte lipoapoptosis. J Biol Chem 2009;284:26591-602. [PMID: 19638343 DOI: 10.1074/jbc.M109.022491] [Cited by in Crossref: 148] [Cited by in F6Publishing: 99] [Article Influence: 11.4] [Reference Citation Analysis]
37 Feng Y, Chen Y, Yang B, Lan Q, Wang T, Cui G, Ren Z, Choi IC, Leung GP, Yan F, Chen D, Yu HH, Lee SMY. Hepatoprotective Effect of Jianpi Huoxue Formula on Nonalcoholic Fatty Liver Disease Induced by Methionine-Choline-Deficient Diet in Rat. Biomed Res Int 2019;2019:7465272. [PMID: 31355279 DOI: 10.1155/2019/7465272] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
38 Akazawa Y, Cazanave S, Mott JL, Elmi N, Bronk SF, Kohno S, Charlton MR, Gores GJ. Palmitoleate attenuates palmitate-induced Bim and PUMA up-regulation and hepatocyte lipoapoptosis. J Hepatol. 2010;52:586-593. [PMID: 20206402 DOI: 10.1016/j.jhep.2010.01.003] [Cited by in Crossref: 151] [Cited by in F6Publishing: 143] [Article Influence: 12.6] [Reference Citation Analysis]
39 Chen G, Xu R, Zhang S, Wang Y, Wang P, Edin ML, Zeldin DC, Wang DW. CYP2J2 overexpression attenuates nonalcoholic fatty liver disease induced by high-fat diet in mice. Am J Physiol Endocrinol Metab 2015;308:E97-E110. [PMID: 25389366 DOI: 10.1152/ajpendo.00366.2014] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 3.8] [Reference Citation Analysis]
40 Tan TC, Crawford DH, Jaskowski LA, Subramaniam VN, Clouston AD, Crane DI, Bridle KR, Anderson GJ, Fletcher LM. Excess iron modulates endoplasmic reticulum stress-associated pathways in a mouse model of alcohol and high-fat diet-induced liver injury. Lab Invest. 2013;93:1295-1312. [PMID: 24126888 DOI: 10.1038/labinvest.2013.121] [Cited by in Crossref: 61] [Cited by in F6Publishing: 62] [Article Influence: 6.8] [Reference Citation Analysis]
41 Iio A, Ito M, Itoh T, Terazawa R, Fujita Y, Nozawa Y, Ohsawa I, Ohno K, Ito M. Molecular hydrogen attenuates fatty acid uptake and lipid accumulation through downregulating CD36 expression in HepG2 cells. Med Gas Res. 2013;3:6. [PMID: 23448206 DOI: 10.1186/2045-9912-3-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
42 Wu P, Jiang W, Liu Y, Chen G, Jiang J, Li S, Feng L, Zhou X. Effect of choline on antioxidant defenses and gene expressions of Nrf2 signaling molecule in the spleen and head kidney of juvenile Jian carp (Cyprinus carpio var. Jian). Fish & Shellfish Immunology 2014;38:374-82. [DOI: 10.1016/j.fsi.2014.03.032] [Cited by in Crossref: 78] [Cited by in F6Publishing: 70] [Article Influence: 9.8] [Reference Citation Analysis]
43 Han D, Shinohara M, Ybanez MD, Saberi B, Kaplowitz N. Signal transduction pathways involved in drug-induced liver injury. Handb Exp Pharmacol. 2010;267-310. [PMID: 20020266 DOI: 10.1007/978-3-642-00663-0_10] [Cited by in Crossref: 78] [Cited by in F6Publishing: 79] [Article Influence: 6.5] [Reference Citation Analysis]
44 Parola M, Marra F. Adipokines and Redox Signaling: Impact on Fatty Liver Disease. Antioxidants & Redox Signaling 2011;15:461-83. [DOI: 10.1089/ars.2010.3848] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 3.5] [Reference Citation Analysis]
45 Mridha AR, Haczeyni F, Yeh MM, Haigh WG, Ioannou GN, Barn V, Ajamieh H, Adams L, Hamdorf JM, Teoh NC, Farrell GC. TLR9 is up-regulated in human and murine NASH: pivotal role in inflammatory recruitment and cell survival. Clin Sci (Lond). 2017;131:2145-2159. [PMID: 28687713 DOI: 10.1042/cs20160838] [Cited by in Crossref: 38] [Cited by in F6Publishing: 25] [Article Influence: 7.6] [Reference Citation Analysis]
46 Bruschi FV, Claudel T, Tardelli M, Caligiuri A, Stulnig TM, Marra F, Trauner M. The PNPLA3 I148M variant modulates the fibrogenic phenotype of human hepatic stellate cells. Hepatology 2017;65:1875-90. [PMID: 28073161 DOI: 10.1002/hep.29041] [Cited by in Crossref: 103] [Cited by in F6Publishing: 103] [Article Influence: 20.6] [Reference Citation Analysis]
47 Anwer MS. INTRACELLULAR SIGNALING BY BILE ACIDS. J Biosci (Rajshari) 2012;20:1-23. [PMID: 25378891 DOI: 10.3329/jbs.v20i0.17647] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
48 Pfaffenbach KT, Gentile CL, Nivala AM, Wang D, Wei Y, Pagliassotti MJ. Linking endoplasmic reticulum stress to cell death in hepatocytes: roles of C/EBP homologous protein and chemical chaperones in palmitate-mediated cell death. Am J Physiol Endocrinol Metab. 2010;298:E1027-E1035. [PMID: 20159858 DOI: 10.1152/ajpendo.00642.2009] [Cited by in Crossref: 124] [Cited by in F6Publishing: 126] [Article Influence: 10.3] [Reference Citation Analysis]
49 Shearn CT, Reigan P, Petersen DR. Inhibition of hydrogen peroxide signaling by 4-hydroxynonenal due to differential regulation of Akt1 and Akt2 contributes to decreases in cell survival and proliferation in hepatocellular carcinoma cells. Free Radic Biol Med 2012;53:1-11. [PMID: 22580126 DOI: 10.1016/j.freeradbiomed.2012.04.021] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
50 Hebbard L, George J. Animal models of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol. 2011;8:35-44. [PMID: 21119613 DOI: 10.1038/nrgastro.2010.191] [Cited by in Crossref: 295] [Cited by in F6Publishing: 292] [Article Influence: 24.6] [Reference Citation Analysis]
51 Alzahrani B, Iseli TJ, Hebbard LW. Non-viral causes of liver cancer: does obesity led inflammation play a role? Cancer Lett. 2014;345:223-229. [PMID: 24007864 DOI: 10.1016/j.canlet.2013.08.036] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 4.0] [Reference Citation Analysis]
52 Li Z, Li Y, Zhang HX, Guo JR, Lam CWK, Wang CY, Zhang W. Mitochondria-Mediated Pathogenesis and Therapeutics for Non-Alcoholic Fatty Liver Disease. Mol Nutr Food Res 2019;63:e1900043. [PMID: 31199058 DOI: 10.1002/mnfr.201900043] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
53 Luo Y, Dong X, Yu Y, Sun G, Sun X. Total aralosides of aralia elata (Miq) seem (TASAES) ameliorate nonalcoholic steatohepatitis by modulating IRE1α-mediated JNK and NF-κB pathways in ApoE-/- mice. J Ethnopharmacol. 2015;163:241-250. [PMID: 25655997 DOI: 10.1016/j.jep.2015.01.017] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 4.9] [Reference Citation Analysis]
54 Zadjali F, Santana-Farre R, Vesterlund M, Carow B, Mirecki-Garrido M, Hernandez-Hernandez I, Flodström-Tullberg M, Parini P, Rottenberg M, Norstedt G. SOCS2 deletion protects against hepatic steatosis but worsens insulin resistance in high-fat-diet-fed mice. FASEB J. 2012;26:3282-3291. [PMID: 22562833 DOI: 10.1096/fj.12-205583] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 4.1] [Reference Citation Analysis]
55 Maher JJ, Leon P, Ryan JC. Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis. Hepatology. 2008;48:670-678. [PMID: 18666225 DOI: 10.1002/hep.22399] [Cited by in Crossref: 136] [Cited by in F6Publishing: 143] [Article Influence: 9.7] [Reference Citation Analysis]
56 Chen Z, Tian R, She Z, Cai J, Li H. Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease. Free Radic Biol Med 2020;152:116-41. [PMID: 32156524 DOI: 10.1016/j.freeradbiomed.2020.02.025] [Cited by in Crossref: 90] [Cited by in F6Publishing: 82] [Article Influence: 45.0] [Reference Citation Analysis]
57 Kim YM, Kim TH, Kim YW, Yang YM, Ryu DH, Hwang SJ, Lee JR, Kim SC, Kim SG. Inhibition of liver X receptor-α-dependent hepatic steatosis by isoliquiritigenin, a licorice antioxidant flavonoid, as mediated by JNK1 inhibition. Free Radic Biol Med 2010;49:1722-34. [PMID: 20840863 DOI: 10.1016/j.freeradbiomed.2010.09.001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
58 Schattenberg JM, Schuchmann M. Diabetes and apoptosis: liver. Apoptosis 2009;14:1459-71. [PMID: 19544096 DOI: 10.1007/s10495-009-0366-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
59 Rinella ME, Siddiqui MS, Gardikiotes K, Gottstein J, Elias M, Green RM. Dysregulation of the unfolded protein response in db/db mice with diet-induced steatohepatitis. Hepatology 2011;54:1600-9. [PMID: 21748768 DOI: 10.1002/hep.24553] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 4.2] [Reference Citation Analysis]
60 Guo T, Woo SL, Guo X, Li H, Zheng J, Botchlett R, Liu M, Pei Y, Xu H, Cai Y, Zeng T, Chen L, Li X, Li Q, Xiao X, Huo Y, Wu C. Berberine Ameliorates Hepatic Steatosis and Suppresses Liver and Adipose Tissue Inflammation in Mice with Diet-induced Obesity. Sci Rep 2016;6:22612. [PMID: 26936230 DOI: 10.1038/srep22612] [Cited by in Crossref: 53] [Cited by in F6Publishing: 56] [Article Influence: 8.8] [Reference Citation Analysis]
61 Di Naso FC, Porto RR, Fillmann HS, Maggioni L, Padoin AV, Ramos RJ, Mottin CC, Bittencourt A, Marroni NA, de Bittencourt PI. Obesity depresses the anti-inflammatory HSP70 pathway, contributing to NAFLD progression. Obesity (Silver Spring). 2015;23:120-129. [PMID: 25292174 DOI: 10.1002/oby.20919] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 6.9] [Reference Citation Analysis]
62 Iwaisako K, Hatano E, Taura K, Nakajima A, Tada M, Seo S, Tamaki N, Sato F, Ikai I, Uemoto S, Kinoshita M. Loss of Sept4 exacerbates liver fibrosis through the dysregulation of hepatic stellate cells. J Hepatol 2008;49:768-78. [PMID: 18804890 DOI: 10.1016/j.jhep.2008.05.026] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis]
63 Csak T, Velayudham A, Hritz I, Petrasek J, Levin I, Lippai D, Catalano D, Mandrekar P, Dolganiuc A, Kurt-Jones E, Szabo G. Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice. Am J Physiol Gastrointest Liver Physiol. 2011;300:G433-G441. [PMID: 21233280 DOI: 10.1152/ajpgi.00163.2009] [Cited by in Crossref: 152] [Cited by in F6Publishing: 156] [Article Influence: 13.8] [Reference Citation Analysis]
64 Ishizuka Y, Nakayama K, Ogawa A, Makishima S, Boonvisut S, Hirao A, Iwasaki Y, Yada T, Yanagisawa Y, Miyashita H, Takahashi M, Iwamoto S, _ _. TRIB1 downregulates hepatic lipogenesis and glycogenesis via multiple molecular interactions. Journal of Molecular Endocrinology 2014;52:145-58. [DOI: 10.1530/jme-13-0243] [Cited by in Crossref: 32] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
65 Liu Q, Rehman H, Krishnasamy Y, Schnellmann RG, Lemasters JJ, Zhong Z. Improvement of liver injury and survival by JNK2 and iNOS deficiency in liver transplants from cardiac death mice. J Hepatol 2015;63:68-74. [PMID: 25703084 DOI: 10.1016/j.jhep.2015.02.017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
66 Rahman SM, Schroeder-gloeckler JM, Janssen RC, Jiang H, Qadri I, Maclean KN, Friedman JE. CCAAT/enhancing binding protein β deletion in mice attenuates inflammation, endoplasmic reticulum stress, and lipid accumulation in diet-induced nonalcoholic steatohepatitis. Hepatology 2007;45:1108-17. [DOI: 10.1002/hep.21614] [Cited by in Crossref: 115] [Cited by in F6Publishing: 117] [Article Influence: 7.7] [Reference Citation Analysis]
67 Baranova A, Schlauch K, Elariny H, Jarrar M, Bennett C, Nugent C, Gowder SJ, Younoszai Z, Collantes R, Chandhoke V, Younossi ZM. Gene Expression Patterns in Hepatic Tissue and Visceral Adipose Tissue of Patients with Non-Alcoholic Fatty Liver Disease. OBES SURG 2007;17:1111-8. [DOI: 10.1007/s11695-007-9187-y] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 2.3] [Reference Citation Analysis]
68 Yan H, Gao Y, Zhang Y. Inhibition of JNK suppresses autophagy and attenuates insulin resistance in a rat model of nonalcoholic fatty liver disease. Mol Med Rep. 2017;15:180-186. [PMID: 27909723 DOI: 10.3892/mmr.2016.5966] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 5.2] [Reference Citation Analysis]
69 Min AK, Kim MK, Kim HS, Seo HY, Lee KU, Kim JG, Park KG, Lee IK. Alpha-lipoic acid attenuates methionine choline deficient diet-induced steatohepatitis in C57BL/6 mice. Life Sci. 2012;90:200-205. [PMID: 22154902 DOI: 10.1016/j.lfs.2011.11.012] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
70 Purohit V, Gao B, Song BJ. Molecular mechanisms of alcoholic fatty liver. Alcohol Clin Exp Res 2009;33:191-205. [PMID: 19032584 DOI: 10.1111/j.1530-0277.2008.00827.x] [Cited by in Crossref: 191] [Cited by in F6Publishing: 187] [Article Influence: 13.6] [Reference Citation Analysis]
71 Kwak DH, Kim JS, Chang KT, Choo YK. Aristolochia manshuriensis Kom ethyl acetate extract protects against high-fat diet-induced non-alcoholic steatohepatitis by regulating kinase phosphorylation in mouse. J Vet Sci 2016;17:279-87. [PMID: 26726030 DOI: 10.4142/jvs.2016.17.3.279] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
72 Bruschi FV, Tardelli M, Herac M, Claudel T, Trauner M. Metabolic regulation of hepatic PNPLA3 expression and severity of liver fibrosis in patients with NASH. Liver Int 2020;40:1098-110. [PMID: 32043752 DOI: 10.1111/liv.14402] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
73 Schattenberg JM, Zimmermann T, Wörns M, Sprinzl MF, Kreft A, Kohl T, Nagel M, Siebler J, Schulze Bergkamen H, He YW, Galle PR, Schuchmann M. Ablation of c-FLIP in hepatocytes enhances death-receptor mediated apoptosis and toxic liver injury in vivo. J Hepatol 2011;55:1272-80. [PMID: 21703207 DOI: 10.1016/j.jhep.2011.03.008] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 4.2] [Reference Citation Analysis]
74 Jian T, Ao X, Wu Y, Lv H, Ma L, Zhao L, Tong B, Ren B, Chen J, Li W. Total sesquiterpene glycosides from Loquat (Eriobotrya japonica) leaf alleviate high-fat diet induced non-alcoholic fatty liver disease through cytochrome P450 2E1 inhibition. Biomed Pharmacother 2017;91:229-37. [PMID: 28458161 DOI: 10.1016/j.biopha.2017.04.056] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
75 Pickens MK, Ogata H, Soon RK, Grenert JP, Maher JJ. Dietary fructose exacerbates hepatocellular injury when incorporated into a methionine-choline-deficient diet. Liver Int 2010;30:1229-39. [PMID: 20536716 DOI: 10.1111/j.1478-3231.2010.02285.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
76 Beck JR, Cabral F, Rasineni K, Casey CA, Harris EN, Stains CI. A Panel of Protein Kinase Chemosensors Distinguishes Different Types of Fatty Liver Disease. Biochemistry 2019;58:3911-7. [PMID: 31433166 DOI: 10.1021/acs.biochem.9b00547] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
77 Jaeschke A, Davis RJ. Metabolic stress signaling mediated by mixed-lineage kinases. Mol Cell. 2007;27:498-508. [PMID: 17679097 DOI: 10.1016/j.molcel.2007.07.008] [Cited by in Crossref: 104] [Cited by in F6Publishing: 106] [Article Influence: 6.9] [Reference Citation Analysis]
78 Cintra DE, Pauli JR, Araújo EP, Moraes JC, de Souza CT, Milanski M, Morari J, Gambero A, Saad MJ, Velloso LA. Interleukin-10 is a protective factor against diet-induced insulin resistance in liver. J Hepatol. 2008;48:628-637. [PMID: 18267346 DOI: 10.1016/j.jhep.2007.12.017] [Cited by in Crossref: 108] [Cited by in F6Publishing: 103] [Article Influence: 7.7] [Reference Citation Analysis]
79 Aibara D, Matsusue K, Matsuo K, Takiguchi S, Gonzalez FJ, Yamano S. Expression of hepatic fat-specific protein 27 depends on the specific etiology of fatty liver. Biol Pharm Bull 2013;36:1766-72. [PMID: 24189421 DOI: 10.1248/bpb.b13-00351] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
80 Han C, Li G, Lim K, DeFrances MC, Gandhi CR, Wu T. Transgenic expression of cyclooxygenase-2 in hepatocytes accelerates endotoxin-induced acute liver failure. J Immunol. 2008;181:8027-8035. [PMID: 19017995 DOI: 10.4049/jimmunol.181.11.8027] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
81 Lian C, Zhai Z, Li Z, Wang L. High fat diet-triggered non-alcoholic fatty liver disease: A review of proposed mechanisms. Chemico-Biological Interactions 2020;330:109199. [DOI: 10.1016/j.cbi.2020.109199] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
82 Cazanave SC, Sanyal AJ. Molecular Mechanisms of Lipotoxicity in Nonalcoholic Fatty Liver Disease. In: Ntambi JM, editor. Hepatic De Novo Lipogenesis and Regulation of Metabolism. Cham: Springer International Publishing; 2016. pp. 101-29. [DOI: 10.1007/978-3-319-25065-6_5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
83 Gerits N, Kostenko S, Moens U. In vivo functions of mitogen-activated protein kinases: conclusions from knock-in and knock-out mice. Transgenic Res 2007;16:281-314. [PMID: 17219248 DOI: 10.1007/s11248-006-9052-0] [Cited by in Crossref: 61] [Cited by in F6Publishing: 62] [Article Influence: 4.1] [Reference Citation Analysis]
84 Cazanave SC, Wang X, Zhou H, Rahmani M, Grant S, Durrant DE, Klaassen CD, Yamamoto M, Sanyal AJ. Degradation of Keap1 activates BH3-only proteins Bim and PUMA during hepatocyte lipoapoptosis. Cell Death Differ 2014;21:1303-12. [PMID: 24769730 DOI: 10.1038/cdd.2014.49] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
85 Peng C, Stewart AG, Woodman OL, Ritchie RH, Qin CX. Non-Alcoholic Steatohepatitis: A Review of Its Mechanism, Models and Medical Treatments. Front Pharmacol 2020;11:603926. [PMID: 33343375 DOI: 10.3389/fphar.2020.603926] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
86 Meijnikman AS, Herrema H, Scheithauer TPM, Kroon J, Nieuwdorp M, Groen AK. Evaluating causality of cellular senescence in non-alcoholic fatty liver disease. JHEP Rep 2021;3:100301. [PMID: 34113839 DOI: 10.1016/j.jhepr.2021.100301] [Reference Citation Analysis]
87 Jung TW, Kang C, Goh J, Chae SI, Kim H, Lee TJ, Abd El‐aty A, Jeong JH. WISP1 promotes non‐alcoholic fatty liver disease and skeletal muscle insulin resistance via TLR4/JNK signaling. J Cell Physiol 2018;233:6077-87. [DOI: 10.1002/jcp.26449] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
88 Aghazadeh S, Yazdanparast R. Inhibition of JNK along with activation of ERK1/2 MAPK pathways improve steatohepatitis among the rats. Clinical Nutrition 2010;29:381-5. [DOI: 10.1016/j.clnu.2009.08.014] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
89 Malaguarnera M, Di Rosa M, Nicoletti F, Malaguarnera L. Molecular mechanisms involved in NAFLD progression. J Mol Med (Berl). 2009;87:679-695. [PMID: 19352614 DOI: 10.1007/s00109-009-0464-1] [Cited by in Crossref: 188] [Cited by in F6Publishing: 174] [Article Influence: 14.5] [Reference Citation Analysis]
90 Shen X, Guo H, Xu J, Wang J. Inhibition of lncRNA HULC improves hepatic fibrosis and hepatocyte apoptosis by inhibiting the MAPK signaling pathway in rats with nonalcoholic fatty liver disease. J Cell Physiol 2019;234:18169-79. [PMID: 30908654 DOI: 10.1002/jcp.28450] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
91 Schattenberg JM, Nagel M, Kim YO, Kohl T, Wörns MA, Zimmermann T, Schad A, Longerich T, Schuppan D, He YW. Increased hepatic fibrosis and JNK2-dependent liver injury in mice exhibiting hepatocyte-specific deletion of cFLIP. Am J Physiol Gastrointest Liver Physiol. 2012;303:G498-G506. [PMID: 22700824 DOI: 10.1152/ajpgi.00525.2011] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
92 Stremmel W, Staffer S, Wannhoff A, Pathil A, Chamulitrat W. Plasma membrane phospholipase A2 controls hepatocellular fatty acid uptake and is responsive to pharmacological modulation: implications for nonalcoholic steatohepatitis. FASEB J. 2014;28:3159-3170. [PMID: 24719358 DOI: 10.1096/fj.14-249763] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
93 Iwamoto S, Boonvisut S, Makishima S, Ishizuka Y, Watanabe K, Nakayama K. The role of TRIB1 in lipid metabolism; from genetics to pathways. Biochem Soc Trans 2015;43:1063-8. [PMID: 26517924 DOI: 10.1042/BST20150094] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
94 Gao L, Wang PX, Zhang Y, Yu CJ, Ji Y, Wang X, Zhang P, Jiang X, Jin H, Huang Z, Zhang ZR, Li H. Tumor necrosis factor receptor-associated factor 5 (Traf5) acts as an essential negative regulator of hepatic steatosis. J Hepatol. 2016;65:125-136. [PMID: 27032381 DOI: 10.1016/j.jhep.2016.03.006] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 5.2] [Reference Citation Analysis]
95 Haeusgen W, Herdegen T, Waetzig V. The bottleneck of JNK signaling: Molecular and functional characteristics of MKK4 and MKK7. European Journal of Cell Biology 2011;90:536-44. [DOI: 10.1016/j.ejcb.2010.11.008] [Cited by in Crossref: 99] [Cited by in F6Publishing: 90] [Article Influence: 9.0] [Reference Citation Analysis]
96 Yang L, Wu D, Wang X, Cederbaum AI. Cytochrome P4502E1, oxidative stress, JNK, and autophagy in acute alcohol-induced fatty liver. Free Radic Biol Med. 2012;53:1170-1180. [PMID: 22749809 DOI: 10.1016/j.freeradbiomed.2012.06.029] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 4.9] [Reference Citation Analysis]
97 Malhi H, Gores GJ. Cellular and molecular mechanisms of liver injury. Gastroenterology 2008;134:1641-54. [PMID: 18471544 DOI: 10.1053/j.gastro.2008.03.002] [Cited by in Crossref: 351] [Cited by in F6Publishing: 325] [Article Influence: 25.1] [Reference Citation Analysis]
98 Zhang QY, Zhao LP, Tian XX, Yan CH, Li Y, Liu YX, Wang PX, Zhang XJ, Han YL. The novel intracellular protein CREG inhibits hepatic steatosis, obesity, and insulin resistance. Hepatology. 2017;66:834-854. [PMID: 28508477 DOI: 10.1002/hep.29257] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
99 Farrell GC, Teoh NC, McCuskey RS. Hepatic microcirculation in fatty liver disease. Anat Rec (Hoboken). 2008;291:684-692. [PMID: 18484615 DOI: 10.1002/ar.20715] [Cited by in Crossref: 166] [Cited by in F6Publishing: 159] [Article Influence: 11.9] [Reference Citation Analysis]
100 Lu Y, Liu X, Jiao Y, Xiong X, Wang E, Wang X, Zhang Z, Zhang H, Pan L, Guan Y, Cai D, Ning G, Li X. Periostin promotes liver steatosis and hypertriglyceridemia through downregulation of PPARα. J Clin Invest 2014;124:3501-13. [PMID: 25003192 DOI: 10.1172/JCI74438] [Cited by in Crossref: 77] [Cited by in F6Publishing: 41] [Article Influence: 9.6] [Reference Citation Analysis]
101 Wang H, Zhu Y, Wang L, Teng T, Zhou M, Wang S, Tian Y, Du L, Yin X, Sun Y. Mangiferin ameliorates fatty liver via modulation of autophagy and inflammation in high-fat-diet induced mice. Biomedicine & Pharmacotherapy 2017;96:328-35. [DOI: 10.1016/j.biopha.2017.10.022] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 5.4] [Reference Citation Analysis]
102 Leclercq IA, Lebrun VA, Stärkel P, Horsmans YJ. Intrahepatic insulin resistance in a murine model of steatohepatitis: effect of PPARgamma agonist pioglitazone. Lab Invest. 2007;87:56-65. [PMID: 17075577 DOI: 10.1038/labinvest.3700489] [Cited by in Crossref: 76] [Cited by in F6Publishing: 74] [Article Influence: 4.8] [Reference Citation Analysis]
103 Pan MH, Lai CS, Tsai ML, Ho CT. Chemoprevention of nonalcoholic fatty liver disease by dietary natural compounds. Mol Nutr Food Res. 2014;58:147-171. [PMID: 24302567 DOI: 10.1002/mnfr.201300522] [Cited by in Crossref: 59] [Cited by in F6Publishing: 57] [Article Influence: 6.6] [Reference Citation Analysis]
104 Salh B. c-Jun N-terminal kinases as potential therapeutic targets. Expert Opin Ther Targets 2007;11:1339-53. [PMID: 17907963 DOI: 10.1517/14728222.11.10.1339] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
105 Vallée D, Blanc M, Lebeaupin C, Bailly-Maitre B. [Endoplasmic reticulum stress response and pathogenesis of non-alcoholic steatohepatitis]. Med Sci (Paris) 2020;36:119-29. [PMID: 32129747 DOI: 10.1051/medsci/2020008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
106 Marra F, Gastaldelli A, Svegliati Baroni G, Tell G, Tiribelli C. Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis. Trends Mol Med. 2008;14:72-81. [PMID: 18218340 DOI: 10.1016/j.molmed.2007.12.003] [Cited by in Crossref: 293] [Cited by in F6Publishing: 288] [Article Influence: 20.9] [Reference Citation Analysis]
107 Rinella ME, Elias MS, Smolak RR, Fu T, Borensztajn J, Green RM. Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet. J Lipid Res. 2008;49:1068-1076. [PMID: 18227531 DOI: 10.1194/jlr.m800042-jlr200] [Cited by in Crossref: 273] [Cited by in F6Publishing: 169] [Article Influence: 19.5] [Reference Citation Analysis]
108 Zhao Y, Wang F, Gao L, Xu L, Tong R, Lin N, Su Y, Yan Y, Gao Y, He J, Kong L, Yuan A, Zhuge Y, Pu J. Ubiquitin-Specific Protease 4 Is an Endogenous Negative Regulator of Metabolic Dysfunctions in Nonalcoholic Fatty Liver Disease in Mice. Hepatology 2018;68:897-917. [DOI: 10.1002/hep.29889] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
109 Ibrahim SH, Hirsova P, Malhi H, Gores GJ. Nonalcoholic Steatohepatitis Promoting Kinases. Semin Liver Dis 2020;40:346-57. [PMID: 32526787 DOI: 10.1055/s-0040-1713115] [Reference Citation Analysis]
110 Stanimirovic J, Obradovic M, Zafirovic S, Resanovic I, Bogdanovic N, Gluvic Z, Mousa SA, Isenovic ER. Effects of altered hepatic lipid metabolism on regulation of hepatic iNOS. Clinical Lipidology 2015;10:167-75. [DOI: 10.2217/clp.15.8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
111 Cederbaum AI, Yang L, Wang X, Wu D. CYP2E1 Sensitizes the Liver to LPS- and TNF α-Induced Toxicity via Elevated Oxidative and Nitrosative Stress and Activation of ASK-1 and JNK Mitogen-Activated Kinases. Int J Hepatol 2012;2012:582790. [PMID: 22028977 DOI: 10.1155/2012/582790] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 3.3] [Reference Citation Analysis]
112 Jung TW, Hwang H, Hong HC, Choi HY, Yoo HJ, Baik SH, Choi KM. Resolvin D1 reduces ER stress-induced apoptosis and triglyceride accumulation through JNK pathway in HepG2 cells. Molecular and Cellular Endocrinology 2014;391:30-40. [DOI: 10.1016/j.mce.2014.04.012] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 5.1] [Reference Citation Analysis]
113 Bae U, Oh M, Park J, Park J, Bae E, Chae S, Cho BH, Park B. Supplementation with Lycium chinense fruit extract attenuates methionine choline-deficient diet-induced steatohepatitis in mice. Journal of Functional Foods 2017;31:1-8. [DOI: 10.1016/j.jff.2017.01.032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
114 Ibrahim SH, Gores GJ. Who pulls the trigger: JNK activation in liver lipotoxicity? J Hepatol. 2012;56:17-19. [PMID: 21703172 DOI: 10.1016/j.jhep.2011.04.017] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
115 Nicholls HT, Hornick JL, Cohen DE. Phosphatidylcholine transfer protein/StarD2 promotes microvesicular steatosis and liver injury in murine experimental steatohepatitis. Am J Physiol Gastrointest Liver Physiol 2017;313:G50-61. [PMID: 28385694 DOI: 10.1152/ajpgi.00379.2016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
116 Ertle J, Dechêne A, Sowa J, Penndorf V, Herzer K, Kaiser G, Schlaak JF, Gerken G, Syn W, Canbay A. Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis: Absence of Cirrhosis in NASH-Derived HCC. Int J Cancer 2011;128:2436-43. [DOI: 10.1002/ijc.25797] [Cited by in Crossref: 290] [Cited by in F6Publishing: 281] [Article Influence: 26.4] [Reference Citation Analysis]
117 Xiao J, Ching YP, Liong EC, Nanji AA, Fung ML, Tipoe GL. Garlic-derived S-allylmercaptocysteine is a hepato-protective agent in non-alcoholic fatty liver disease in vivo animal model. Eur J Nutr. 2013;52:179-191. [PMID: 22278044 DOI: 10.1007/s00394-012-0301-0] [Cited by in Crossref: 68] [Cited by in F6Publishing: 61] [Article Influence: 6.8] [Reference Citation Analysis]
118 Gentile CL, Frye M, Pagliassotti MJ. Endoplasmic reticulum stress and the unfolded protein response in nonalcoholic fatty liver disease. Antioxid Redox Signal. 2011;15:505-521. [PMID: 21128705 DOI: 10.1089/ars.2010.3790] [Cited by in Crossref: 67] [Cited by in F6Publishing: 64] [Article Influence: 6.1] [Reference Citation Analysis]
119 Leamy AK, Egnatchik RA, Young JD. Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease. Prog Lipid Res 2013;52:165-74. [PMID: 23178552 DOI: 10.1016/j.plipres.2012.10.004] [Cited by in Crossref: 232] [Cited by in F6Publishing: 231] [Article Influence: 23.2] [Reference Citation Analysis]
120 Cazanave SC, Gores GJ. Mechanisms and clinical implications of hepatocyte lipoapoptosis. Clin Lipidol. 2010;5:71-85. [PMID: 20368747 DOI: 10.2217/clp.09.85] [Cited by in Crossref: 68] [Cited by in F6Publishing: 61] [Article Influence: 5.7] [Reference Citation Analysis]
121 Masarone M, Rosato V, Dallio M, Gravina AG, Aglitti A, Loguercio C, Federico A, Persico M. Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease. Oxid Med Cell Longev 2018;2018:9547613. [PMID: 29991976 DOI: 10.1155/2018/9547613] [Cited by in Crossref: 205] [Cited by in F6Publishing: 209] [Article Influence: 51.3] [Reference Citation Analysis]
122 Kluwe J, Pradere JP, Gwak GY, Mencin A, De Minicis S, Osterreicher CH, Colmenero J, Bataller R, Schwabe RF. Modulation of hepatic fibrosis by c-Jun-N-terminal kinase inhibition. Gastroenterology. 2010;138:347-359. [PMID: 19782079 DOI: 10.1053/j.gastro.2009.09.015] [Cited by in Crossref: 141] [Cited by in F6Publishing: 142] [Article Influence: 10.8] [Reference Citation Analysis]
123 Kodama Y, Brenner DA. c-Jun N-terminal kinase signaling in the pathogenesis of nonalcoholic fatty liver disease: Multiple roles in multiple steps. Hepatology 2009;49:6-8. [PMID: 19111006 DOI: 10.1002/hep.22710] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 3.2] [Reference Citation Analysis]
124 Hu YB. Mechanisms of non-alcoholic steatohepatitis: pathophysiology and molecular biology. Shijie Huaren Xiaohua Zazhi 2009; 17(13): 1329-1334 [DOI: 10.11569/wcjd.v17.i13.1329] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
125 Sevastou I, Kaffe E, Mouratis M, Aidinis V. Lysoglycerophospholipids in chronic inflammatory disorders: The PLA2/LPC and ATX/LPA axes. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2013;1831:42-60. [DOI: 10.1016/j.bbalip.2012.07.019] [Cited by in Crossref: 144] [Cited by in F6Publishing: 132] [Article Influence: 16.0] [Reference Citation Analysis]
126 Serviddio G, Bellanti F, Vendemiale G, Altomare E. Mitochondrial dysfunction in nonalcoholic steatohepatitis. Expert Rev Gastroenterol Hepatol. 2011;5:233-244. [PMID: 21476918 DOI: 10.1586/egh.11.11] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 4.9] [Reference Citation Analysis]
127 Larter CZ, Yeh MM, Cheng J, Williams J, Brown S, dela Pena A, Bell-anderson KS, Farrell GC. Activation of peroxisome proliferator-activated receptor α by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation. J Gastroenterol Hepatol 2008;23:267-75. [DOI: 10.1111/j.1440-1746.2007.05157.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 3.8] [Reference Citation Analysis]
128 Kluwe J, Pradere JP, Gwak GY, Mencin A, De Minicis S, Osterreicher CH, Colmenero J, Bataller R, Schwabe RF. Modulation of hepatic fibrosis by c-Jun-N-terminal kinase inhibition. Gastroenterology. 2010;138:347-359. [PMID: 19782079 DOI: 10.1053/gastro.2009.09.015] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
129 Aghazadeh S, Amini R, Yazdanparast R, Ghaffari SH. Anti-apoptotic and anti-inflammatory effects of Silybum marianum in treatment of experimental steatohepatitis. Exp Toxicol Pathol 2011;63:569-74. [PMID: 20471811 DOI: 10.1016/j.etp.2010.04.009] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
130 Musso G, Gambino R, De Michieli F, Biroli G, Fagà E, Pagano G, Cassader M. Association of liver disease with postprandial large intestinal triglyceride-rich lipoprotein accumulation and pro/antioxidant imbalance in normolipidemic non-alcoholic steatohepatitis. Annals of Medicine 2009;40:383-94. [DOI: 10.1080/07853890801946515] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
131 Puri P, Mirshahi F, Cheung O, Natarajan R, Maher JW, Kellum JM, Sanyal AJ. Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease. Gastroenterology. 2008;134:568-576. [PMID: 18082745 DOI: 10.1053/j.gastro.2007.10.039] [Cited by in Crossref: 383] [Cited by in F6Publishing: 356] [Article Influence: 25.5] [Reference Citation Analysis]
132 Takahara I, Akazawa Y, Tabuchi M, Matsuda K, Miyaaki H, Kido Y, Kanda Y, Taura N, Ohnita K, Takeshima F, Sakai Y, Eguchi S, Nakashima M, Nakao K. Toyocamycin attenuates free fatty acid-induced hepatic steatosis and apoptosis in cultured hepatocytes and ameliorates nonalcoholic fatty liver disease in mice. PLoS One. 2017;12:e0170591. [PMID: 28278289 DOI: 10.1371/journal.pone.0170591] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
133 Akazawa Y, Nakao K. Lipotoxicity pathways intersect in hepatocytes: Endoplasmic reticulum stress, c-Jun N-terminal kinase-1, and death receptors. Hepatol Res 2016;46:977-84. [PMID: 26938481 DOI: 10.1111/hepr.12658] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
134 Song BJ, Akbar M, Abdelmegeed MA, Byun K, Lee B, Yoon SK, Hardwick JP. Mitochondrial dysfunction and tissue injury by alcohol, high fat, nonalcoholic substances and pathological conditions through post-translational protein modifications. Redox Biol. 2014;3:109-123. [PMID: 25465468 DOI: 10.1016/j.redox.2014.10.004] [Cited by in Crossref: 57] [Cited by in F6Publishing: 53] [Article Influence: 8.1] [Reference Citation Analysis]
135 Hirsova P, Ibrahim SH, Gores GJ, Malhi H. Lipotoxic lethal and sublethal stress signaling in hepatocytes: Relevance to NASH pathogenesis. J Lipid Res. 2016;57:1758-1770. [PMID: 27049024 DOI: 10.1194/jlr.r066357] [Cited by in Crossref: 112] [Cited by in F6Publishing: 72] [Article Influence: 18.7] [Reference Citation Analysis]
136 Kaplowitz N, Shinohara M, Liu Z, Han D. How to Protect Against Acetaminophen: Don't Ask for JUNK. Gastroenterology 2008;135:1047-51. [DOI: 10.1053/j.gastro.2008.08.031] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
137 Larter CZ, Yeh MM, Haigh WG, Williams J, Brown S, Bell-Anderson KS, Lee SP, Farrell GC. Hepatic free fatty acids accumulate in experimental steatohepatitis: role of adaptive pathways. J Hepatol 2008;48:638-47. [PMID: 18280001 DOI: 10.1016/j.jhep.2007.12.011] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 3.9] [Reference Citation Analysis]
138 Kourouma A, Keita H, Duan P, Quan C, Bilivogui KK, Qi S, Christiane NA, Osamuyimen A, Yang K. Effects of 4-nonylphenol on oxidant/antioxidant balance system inducing hepatic steatosis in male rat. Toxicol Rep 2015;2:1423-33. [PMID: 28962484 DOI: 10.1016/j.toxrep.2015.10.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
139 Malhi H, Guicciardi ME, Gores GJ. Hepatocyte death: a clear and present danger. Physiol Rev. 2010;90:1165-1194. [PMID: 20664081 DOI: 10.1152/physrev.00061.2009] [Cited by in Crossref: 294] [Cited by in F6Publishing: 261] [Article Influence: 24.5] [Reference Citation Analysis]
140 Corrao S, Natoli G, Argano C. Nonalcoholic fatty liver disease is associated with intrahepatic cholangiocarcinoma and not with extrahepatic form: definitive evidence from meta-analysis and trial sequential analysis. Eur J Gastroenterol Hepatol 2021;33:62-8. [PMID: 32091438 DOI: 10.1097/MEG.0000000000001684] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
141 Jia F, Hu X, Kimura T, Tanaka N. Impact of Dietary Fat on the Progression of Liver Fibrosis: Lessons from Animal and Cell Studies. Int J Mol Sci 2021;22:10303. [PMID: 34638640 DOI: 10.3390/ijms221910303] [Reference Citation Analysis]
142 Leclercq IA, Da Silva Morais A, Schroyen B, Van Hul N, Geerts A. Insulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequences. J Hepatol. 2007;47:142-156. [PMID: 17512085 DOI: 10.1016/j.jhep.2007.04.002] [Cited by in Crossref: 210] [Cited by in F6Publishing: 199] [Article Influence: 14.0] [Reference Citation Analysis]
143 Marra F, Lotersztajn S. Pathophysiology of NASH: perspectives for a targeted treatment. Curr Pharm Des. 2013;19:5250-5269. [PMID: 23394092 DOI: 10.2174/1381612811399990344] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
144 Kapoor A, Sanyal AJ. Endoplasmic Reticulum Stress and the Unfolded Protein Response. Clinics in Liver Disease 2009;13:581-90. [DOI: 10.1016/j.cld.2009.07.004] [Cited by in Crossref: 72] [Cited by in F6Publishing: 69] [Article Influence: 5.5] [Reference Citation Analysis]
145 Farrell GC, van Rooyen D, Gan L, Chitturi S. NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications. Gut Liver. 2012;6:149-171. [PMID: 22570745 DOI: 10.5009/gnl.2012.6.2.149] [Cited by in Crossref: 247] [Cited by in F6Publishing: 231] [Article Influence: 24.7] [Reference Citation Analysis]
146 Jia X, Naito H, Yetti H, Tamada H, Kitamori K, Hayashi Y, Yamagishi N, Wang D, Yanagiba Y, Ito Y, Wang J, Tanaka N, Ikeda K, Yamori Y, Nakajima T. The modulation of hepatic adenosine triphosphate and inflammation by eicosapentaenoic acid during severe fibrotic progression in the SHRSP5/Dmcr rat model. Life Sci 2012;90:934-43. [PMID: 22569299 DOI: 10.1016/j.lfs.2012.04.029] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
147 Solinas P, Isola M, Lilliu MA, Conti G, Civolani A, Demelia L, Loy F, Isola R. Animal models are reliably mimicking human diseases? A morphological study that compares animal with human NAFLD. Microsc Res Tech 2014;77:790-6. [PMID: 25044260 DOI: 10.1002/jemt.22401] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
148 Kammoun HL, Hainault I, Ferré P, Foufelle F. Nutritional related liver disease: targeting the endoplasmic reticulum stress: . Current Opinion in Clinical Nutrition and Metabolic Care 2009;12:575-82. [DOI: 10.1097/mco.0b013e32833189db] [Cited by in Crossref: 28] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
149 Ibrahim SH, Gores GJ, Hirsova P, Kirby M, Miles L, Jaeschke A, Kohli R. Mixed lineage kinase 3 deficient mice are protected against the high fat high carbohydrate diet-induced steatohepatitis. Liver Int. 2014;34:427-437. [PMID: 24256559 DOI: 10.1111/liv.12353] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 3.7] [Reference Citation Analysis]
150 Manieri E, Sabio G. Stress kinases in the modulation of metabolism and energy balance. J Mol Endocrinol 2015;55:R11-22. [PMID: 26363062 DOI: 10.1530/JME-15-0146] [Cited by in Crossref: 42] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
151 Ferreira DM, Castro RE, Machado MV, Evangelista T, Silvestre A, Costa A, Coutinho J, Carepa F, Cortez-Pinto H, Rodrigues CM. Apoptosis and insulin resistance in liver and peripheral tissues of morbidly obese patients is associated with different stages of non-alcoholic fatty liver disease. Diabetologia. 2011;54:1788-1798. [PMID: 21455726 DOI: 10.1007/s00125-011-2130-8] [Cited by in Crossref: 62] [Cited by in F6Publishing: 61] [Article Influence: 5.6] [Reference Citation Analysis]
152 Sabapathy K. Role of the JNK pathway in human diseases. Prog Mol Biol Transl Sci. 2012;106:145-169. [PMID: 22340717 DOI: 10.1016/B978-0-12-396456-4.00013-4] [Cited by in Crossref: 86] [Cited by in F6Publishing: 50] [Article Influence: 8.6] [Reference Citation Analysis]
153 Cao J, Feng XX, Yao L, Ning B, Yang ZX, Fang DL, Shen W. Saturated free fatty acid sodium palmitate-induced lipoapoptosis by targeting glycogen synthase kinase-3β activation in human liver cells. Dig Dis Sci 2014;59:346-57. [PMID: 24132507 DOI: 10.1007/s10620-013-2896-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
154 Kohl T, Gehrke N, Schad A, Nagel M, Wörns MA, Sprinzl MF, Zimmermann T, He YW, Galle PR, Schuchmann M, Schattenberg JM. Diabetic liver injury from streptozotocin is regulated through the caspase-8 homolog cFLIP involving activation of JNK2 and intrahepatic immunocompetent cells. Cell Death Dis 2013;4:e712. [PMID: 23828575 DOI: 10.1038/cddis.2013.228] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
155 Ibrahim SH, Kohli R, Gores GJ. Mechanisms of lipotoxicity in NAFLD and clinical implications. J Pediatr Gastroenterol Nutr 2011;53:131-40. [PMID: 21629127 DOI: 10.1097/MPG.0b013e31822578db] [Cited by in Crossref: 50] [Cited by in F6Publishing: 81] [Article Influence: 4.5] [Reference Citation Analysis]
156 Asrih M, Jornayvaz FR. Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link? Molecular and Cellular Endocrinology 2015;418:55-65. [DOI: 10.1016/j.mce.2015.02.018] [Cited by in Crossref: 150] [Cited by in F6Publishing: 152] [Article Influence: 21.4] [Reference Citation Analysis]
157 Najjar SM, Russo L. CEACAM1 loss links inflammation to insulin resistance in obesity and non-alcoholic steatohepatitis (NASH). Semin Immunopathol. 2014;36:55-71. [PMID: 24258517 DOI: 10.1007/s00281-013-0407-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
158 Roberts EA. Non-alcoholic steatohepatitis in children. Clin Liver Dis. 2007;11:155-172, x. [PMID: 17544977 DOI: 10.1016/j.cld.2007.02.008] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 2.6] [Reference Citation Analysis]
159 Radwan MM, Radwan BM, Nandipati KC, Hunter WJ, Agrawal DK. Immunological and molecular basis of nonalcoholic steatohepatitis and nonalcoholic fatty liver disease. Expert Rev Clin Immunol. 2013;9:727-738. [PMID: 23971751 DOI: 10.1586/1744666x.2013.816484] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
160 Méndez-Sánchez N, Arrese M, Zamora-Valdés D, Uribe M. Current concepts in the pathogenesis of nonalcoholic fatty liver disease. Liver Int. 2007;27:423-433. [PMID: 17403181 DOI: 10.1111/j.1478-3231.2007.01483.x] [Cited by in Crossref: 116] [Cited by in F6Publishing: 120] [Article Influence: 7.7] [Reference Citation Analysis]
161 Larter CZ, Yeh MM, Williams J, Bell-Anderson KS, Farrell GC. MCD-induced steatohepatitis is associated with hepatic adiponectin resistance and adipogenic transformation of hepatocytes. J Hepatol. 2008;49:407-416. [PMID: 18534710 DOI: 10.1016/j.jhep.2008.03.026] [Cited by in Crossref: 82] [Cited by in F6Publishing: 77] [Article Influence: 5.9] [Reference Citation Analysis]
162 Svegliati-Baroni G, Candelaresi C, Saccomanno S, Ferretti G, Bachetti T, Marzioni M, De Minicis S, Nobili L, Salzano R, Omenetti A, Pacetti D, Sigmund S, Benedetti A, Casini A. A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury. Am J Pathol 2006;169:846-60. [PMID: 16936261 DOI: 10.2353/ajpath.2006.050953] [Cited by in Crossref: 191] [Cited by in F6Publishing: 183] [Article Influence: 11.9] [Reference Citation Analysis]
163 Gambino R, Musso G, Cassader M. Redox balance in the pathogenesis of nonalcoholic fatty liver disease: mechanisms and therapeutic opportunities. Antioxid Redox Signal. 2011;15:1325-1365. [PMID: 20969475 DOI: 10.1089/ars.2009.3058] [Cited by in Crossref: 97] [Cited by in F6Publishing: 98] [Article Influence: 8.8] [Reference Citation Analysis]
164 Amir M, Liu K, Zhao E, Czaja MJ. Distinct functions of JNK and c-Jun in oxidant-induced hepatocyte death. J Cell Biochem 2012;113:3254-65. [PMID: 22644775 DOI: 10.1002/jcb.24203] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
165 Sabio G, Cavanagh-Kyros J, Ko HJ, Jung DY, Gray S, Jun JY, Barrett T, Mora A, Kim JK, Davis RJ. Prevention of steatosis by hepatic JNK1. Cell Metab 2009;10:491-8. [PMID: 19945406 DOI: 10.1016/j.cmet.2009.09.007] [Cited by in Crossref: 105] [Cited by in F6Publishing: 103] [Article Influence: 8.8] [Reference Citation Analysis]
166 Peverill W, Powell LW, Skoien R. Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation. Int J Mol Sci 2014;15:8591-638. [PMID: 24830559 DOI: 10.3390/ijms15058591] [Cited by in Crossref: 178] [Cited by in F6Publishing: 164] [Article Influence: 22.3] [Reference Citation Analysis]
167 Singh R, Xiang Y, Wang Y, Baikati K, Cuervo AM, Luu YK, Tang Y, Pessin JE, Schwartz GJ, Czaja MJ. Autophagy regulates adipose mass and differentiation in mice. J Clin Invest. 2009;119:3329-3339. [PMID: 19855132 DOI: 10.1172/jci39228] [Cited by in Crossref: 80] [Cited by in F6Publishing: 321] [Article Influence: 6.2] [Reference Citation Analysis]
168 Litwinowicz K, Waszczuk E, Gamian A. Advanced Glycation End-Products in Common Non-Infectious Liver Diseases: Systematic Review and Meta-Analysis. Nutrients 2021;13:3370. [PMID: 34684371 DOI: 10.3390/nu13103370] [Reference Citation Analysis]
169 Shabgah AG, Norouzi F, Hedayati-Moghadam M, Soleimani D, Pahlavani N, Navashenaq JG. A comprehensive review of long non-coding RNAs in the pathogenesis and development of non-alcoholic fatty liver disease. Nutr Metab (Lond) 2021;18:22. [PMID: 33622377 DOI: 10.1186/s12986-021-00552-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
170 Zhong X, Liu H. Baicalin attenuates diet induced nonalcoholic steatohepatitis by inhibiting inflammation and oxidative stress via suppressing JNK signaling pathways. Biomed Pharmacother 2018;98:111-7. [PMID: 29247950 DOI: 10.1016/j.biopha.2017.12.026] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
171 Sommerfeld A, Reinehr R, Häussinger D. Free fatty acids shift insulin-induced hepatocyte proliferation towards CD95-dependent apoptosis. J Biol Chem 2015;290:4398-409. [PMID: 25548285 DOI: 10.1074/jbc.M114.617035] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
172 Amini R, Yazdanparast R, Aghazadeh S, Ghaffari SH. Teucrium polium reversed the MCD diet-induced liver injury in rats. Hum Exp Toxicol 2011;30:1303-12. [PMID: 21056947 DOI: 10.1177/0960327110388961] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
173 Noureddin M, Rinella ME. Nonalcoholic Fatty liver disease, diabetes, obesity, and hepatocellular carcinoma. Clin Liver Dis 2015;19:361-79. [PMID: 25921668 DOI: 10.1016/j.cld.2015.01.012] [Cited by in Crossref: 94] [Cited by in F6Publishing: 88] [Article Influence: 13.4] [Reference Citation Analysis]
174 Akazawa Y, Nakao K. To die or not to die: death signaling in nonalcoholic fatty liver disease. J Gastroenterol 2018;53:893-906. [PMID: 29574534 DOI: 10.1007/s00535-018-1451-5] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 9.3] [Reference Citation Analysis]
175 Schulien I, Hockenjos B, Schmitt-Graeff A, Perdekamp MG, Follo M, Thimme R, Hasselblatt P. The transcription factor c-Jun/AP-1 promotes liver fibrosis during non-alcoholic steatohepatitis by regulating Osteopontin expression. Cell Death Differ 2019;26:1688-99. [PMID: 30778201 DOI: 10.1038/s41418-018-0239-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
176 Lee JY, Moon JH, Park JS, Lee BW, Kang ES, Ahn CW, Lee HC, Cha BS. Dietary oleate has beneficial effects on every step of non-alcoholic Fatty liver disease progression in a methionine- and choline-deficient diet-fed animal model. Diabetes Metab J 2011;35:489-96. [PMID: 22111040 DOI: 10.4093/dmj.2011.35.5.489] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
177 Li W, Zheng L, Sheng C, Cheng X, Qing L, Qu S. Systematic review on the treatment of pentoxifylline in patients with non-alcoholic fatty liver disease. Lipids Health Dis. 2011;10:49. [PMID: 21477300 DOI: 10.1186/1476-511x-10-49] [Cited by in Crossref: 53] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
178 Vinué Á, Herrero-Cervera A, González-Navarro H. Understanding the Impact of Dietary Cholesterol on Chronic Metabolic Diseases through Studies in Rodent Models. Nutrients 2018;10:E939. [PMID: 30037080 DOI: 10.3390/nu10070939] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
179 Magdy YM, El-kharashi OA, Nabih ES, Shaker SM, Abd-elaziz LF, Aboul-fotouh S. Potential involvement of JNK1 repression in the hepatic effect of sitagliptin and metformin in rats subjected to high fat diet and chronic mild distress. Biomedicine & Pharmacotherapy 2017;85:225-38. [DOI: 10.1016/j.biopha.2016.10.098] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
180 Imarisio C, Alchera E, Sutti S, Valente G, Boccafoschi F, Albano E, Carini R. Adenosine A(2a) receptor stimulation prevents hepatocyte lipotoxicity and non-alcoholic steatohepatitis (NASH) in rats. Clin Sci (Lond). 2012;123:323-332. [PMID: 22439844 DOI: 10.1042/cs20110504] [Cited by in Crossref: 29] [Cited by in F6Publishing: 12] [Article Influence: 2.9] [Reference Citation Analysis]
181 Cicuéndez B, Ruiz-Garrido I, Mora A, Sabio G. Stress kinases in the development of liver steatosis and hepatocellular carcinoma. Mol Metab 2021;50:101190. [PMID: 33588102 DOI: 10.1016/j.molmet.2021.101190] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
182 Martyn JA, Kaneki M, Yasuhara S. Obesity-induced insulin resistance and hyperglycemia: etiologic factors and molecular mechanisms. Anesthesiology. 2008;109:137-148. [PMID: 18580184 DOI: 10.1097/aln.0b013e3181799d45] [Cited by in Crossref: 111] [Cited by in F6Publishing: 49] [Article Influence: 7.9] [Reference Citation Analysis]
183 Singh R, Wang Y, Schattenberg JM, Xiang Y, Czaja MJ. Chronic oxidative stress sensitizes hepatocytes to death from 4-hydroxynonenal by JNK/c-Jun overactivation. Am J Physiol Gastrointest Liver Physiol 2009;297:G907-17. [PMID: 20501438 DOI: 10.1152/ajpgi.00151.2009] [Cited by in Crossref: 50] [Cited by in F6Publishing: 42] [Article Influence: 4.2] [Reference Citation Analysis]
184 Miura K, Seki E, Ohnishi H, Brenner DA. Role of toll-like receptors and their downstream molecules in the development of nonalcoholic Fatty liver disease. Gastroenterol Res Pract 2010;2010:362847. [PMID: 21274430 DOI: 10.1155/2010/362847] [Cited by in Crossref: 99] [Cited by in F6Publishing: 105] [Article Influence: 9.0] [Reference Citation Analysis]
185 Andrés-Blasco I, Herrero-Cervera A, Vinué Á, Martínez-Hervás S, Piqueras L, Sanz MJ, Burks DJ, González-Navarro H. Hepatic lipase deficiency produces glucose intolerance, inflammation and hepatic steatosis. J Endocrinol 2015;227:179-91. [PMID: 26423094 DOI: 10.1530/JOE-15-0219] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
186 Moseley RH. Liver and biliary tract disorders. Curr Opin Gastroenterol 2006;22:193-7. [PMID: 16550032 DOI: 10.1097/01.mog.0000218954.17570.06] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
187 Serviddio G, Sastre J, Bellanti F, Viña J, Vendemiale G, Altomare E. Mitochondrial involvement in non-alcoholic steatohepatitis. Mol Aspects Med 2008;29:22-35. [PMID: 18061659 DOI: 10.1016/j.mam.2007.09.014] [Cited by in Crossref: 64] [Cited by in F6Publishing: 68] [Article Influence: 4.3] [Reference Citation Analysis]
188 Yan H, Gao Y, Zhang Y, Wang H, Liu G, Lei J. Chlorogenic acid alleviates autophagy and insulin resistance by suppressing JNK pathway in a rat model of nonalcoholic fatty liver disease. J Biosci 2018;43:287-94. [DOI: 10.1007/s12038-018-9746-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 4.8] [Reference Citation Analysis]
189 Shinozaki S, Choi CS, Shimizu N, Yamada M, Kim M, Zhang T, Shiota G, Dong HH, Kim YB, Kaneki M. Liver-specific inducible nitric-oxide synthase expression is sufficient to cause hepatic insulin resistance and mild hyperglycemia in mice. J Biol Chem 2011;286:34959-75. [PMID: 21846719 DOI: 10.1074/jbc.M110.187666] [Cited by in Crossref: 44] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
190 Xiao J, Liong EC, Ching YP, Chang RC, Fung ML, Xu AM, So KF, Tipoe GL. Lycium barbarum polysaccharides protect rat liver from non-alcoholic steatohepatitis-induced injury. Nutr Diabetes 2013;3:e81. [PMID: 23877747 DOI: 10.1038/nutd.2013.22] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 5.3] [Reference Citation Analysis]
191 Harmon RC, Tiniakos DG, Argo CK. Inflammation in nonalcoholic steatohepatitis. Expert Review of Gastroenterology & Hepatology 2014;5:189-200. [DOI: 10.1586/egh.11.21] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 7.0] [Reference Citation Analysis]
192 Iyer S, Upadhyay PK, Majumdar SS, Nagarajan P. Animal Models Correlating Immune Cells for the Development of NAFLD/NASH. J Clin Exp Hepatol 2015;5:239-45. [PMID: 26628841 DOI: 10.1016/j.jceh.2015.06.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
193 Jia G, Kong R, Ma ZB, Han B, Wang YW, Pan SH, Li YH, Sun B. The activation of c-Jun NH₂-terminal kinase is required for dihydroartemisinin-induced autophagy in pancreatic cancer cells. J Exp Clin Cancer Res 2014;33:8. [PMID: 24438216 DOI: 10.1186/1756-9966-33-8] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 5.3] [Reference Citation Analysis]
194 Huber Y, Gehrke N, Biedenbach J, Helmig S, Simon P, Straub BK, Bergheim I, Huber T, Schuppan D, Galle PR, Wörns MA, Schuchmann M, Schattenberg JM. Voluntary distance running prevents TNF-mediated liver injury in mice through alterations of the intrahepatic immune milieu. Cell Death Dis 2017;8:e2893. [PMID: 28640248 DOI: 10.1038/cddis.2017.266] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
195 Lebeaupin C, Vallée D, Hazari Y, Hetz C, Chevet E, Bailly-Maitre B. Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease. J Hepatol 2018;69:927-47. [PMID: 29940269 DOI: 10.1016/j.jhep.2018.06.008] [Cited by in Crossref: 198] [Cited by in F6Publishing: 195] [Article Influence: 49.5] [Reference Citation Analysis]
196 Cederbaum AI. CYP2E1- and TNFalpha/LPS-Induced Oxidative Stress and MAPK Signaling Pathways in Alcoholic Liver Disease. Curr Pathobiol Rep 2015;3:263-72. [DOI: 10.1007/s40139-015-0092-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
197 Bai L, Li H. Innate immune regulatory networks in hepatic lipid metabolism. J Mol Med (Berl). 2019;97:593-604. [PMID: 30891617 DOI: 10.1007/s00109-019-01765-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 7.7] [Reference Citation Analysis]
198 Van Rooyen DM, Gan LT, Yeh MM, Haigh WG, Larter CZ, Ioannou G, Teoh NC, Farrell GC. Pharmacological cholesterol lowering reverses fibrotic NASH in obese, diabetic mice with metabolic syndrome. Journal of Hepatology 2013;59:144-52. [DOI: 10.1016/j.jhep.2013.02.024] [Cited by in Crossref: 79] [Cited by in F6Publishing: 77] [Article Influence: 8.8] [Reference Citation Analysis]
199 Kuchay MS, Choudhary NS, Mishra SK. Pathophysiological mechanisms underlying MAFLD. Diabetes Metab Syndr 2020;14:1875-87. [PMID: 32998095 DOI: 10.1016/j.dsx.2020.09.026] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
200 London RM, George J. Pathogenesis of NASH: Animal Models. Clinics in Liver Disease 2007;11:55-74. [DOI: 10.1016/j.cld.2007.02.010] [Cited by in Crossref: 71] [Cited by in F6Publishing: 71] [Article Influence: 4.7] [Reference Citation Analysis]
201 Valenti L, Ludovica Fracanzani A, Fargion S. The immunopathogenesis of alcoholic and nonalcoholic steatohepatitis: two triggers for one disease? Semin Immunopathol 2009;31:359-69. [DOI: 10.1007/s00281-009-0152-9] [Cited by in Crossref: 48] [Cited by in F6Publishing: 52] [Article Influence: 3.7] [Reference Citation Analysis]
202 Zhao L, Zhang C, Luo X, Wang P, Zhou W, Zhong S, Xie Y, Jiang Y, Yang P, Tang R, Pan Q, Hall AR, Luong TV, Fan J, Varghese Z, Moorhead JF, Pinzani M, Chen Y, Ruan XZ. CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitis. J Hepatol 2018;69:705-17. [PMID: 29705240 DOI: 10.1016/j.jhep.2018.04.006] [Cited by in Crossref: 46] [Cited by in F6Publishing: 50] [Article Influence: 11.5] [Reference Citation Analysis]
203 Shen T, Chen X, Li Y, Tang X, Jiang X, Yu C, Zheng Y, Guo H, Ling W. Interleukin-17A exacerbates high-fat diet-induced hepatic steatosis by inhibiting fatty acid β-oxidation. Biochim Biophys Acta Mol Basis Dis 2017;1863:1510-8. [PMID: 28153707 DOI: 10.1016/j.bbadis.2017.01.027] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
204 Pardo V, González-Rodríguez Á, Muntané J, Kozma SC, Valverde ÁM. Role of hepatocyte S6K1 in palmitic acid-induced endoplasmic reticulum stress, lipotoxicity, insulin resistance and in oleic acid-induced protection. Food Chem Toxicol 2015;80:298-309. [PMID: 25846498 DOI: 10.1016/j.fct.2015.03.029] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 6.7] [Reference Citation Analysis]
205 Engin A. Non-Alcoholic Fatty Liver Disease. In: Engin AB, Engin A, editors. Obesity and Lipotoxicity. Cham: Springer International Publishing; 2017. pp. 443-67. [DOI: 10.1007/978-3-319-48382-5_19] [Cited by in Crossref: 85] [Cited by in F6Publishing: 87] [Article Influence: 17.0] [Reference Citation Analysis]
206 Kassel KM, Guo GL, Tawfik O, Luyendyk JP. Monocyte chemoattractant protein-1 deficiency does not affect steatosis or inflammation in livers of mice fed a methionine-choline-deficient diet. Lab Invest. 2010;90:1794-1804. [PMID: 20697377 DOI: 10.1038/labinvest.2010.143] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
207 Lu S, Bennett RG, Kharbanda KK, Harrison-Findik DD. Lack of hepcidin expression attenuates steatosis and causes fibrosis in the liver. World J Hepatol 2016; 8(4): 211-225 [PMID: 26855692 DOI: 10.4254/wjh.v8.i4.211] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
208 Graczyk PP. JNK inhibitors as anti-inflammatory and neuroprotective agents. Future Med Chem 2013;5:539-51. [PMID: 23573972 DOI: 10.4155/fmc.13.34] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
209 Yu J, Chu ES, Wang R, Wang S, Wu CW, Wong VW, Chan HL, Farrell GC, Sung JJ. Heme oxygenase-1 protects against steatohepatitis in both cultured hepatocytes and mice. Gastroenterology. 2010;138:694-704, 704.e1. [PMID: 19818781 DOI: 10.1053/j.gastro.2009.09.058] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 3.8] [Reference Citation Analysis]
210 Larter CZ, Yeh MM. Animal models of NASH: getting both pathology and metabolic context right. J Gastroenterol Hepatol. 2008;23:1635-1648. [PMID: 18752564 DOI: 10.1111/j.1440-1746.2008.05543.x] [Cited by in Crossref: 236] [Cited by in F6Publishing: 231] [Article Influence: 16.9] [Reference Citation Analysis]
211 García-Lastra R, San-Miguel B, Crespo I, Jorquera F, Alvarez M, González-Gallego J, Tuñón MJ. Signaling pathways involved in liver injury and regeneration in rabbit hemorrhagic disease, an animal model of virally-induced fulminant hepatic failure. Vet Res 2010;41:2. [PMID: 19726019 DOI: 10.1051/vetres/2009050] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
212 Williams KH, Shackel NA, Gorrell MD, McLennan SV, Twigg SM. Diabetes and nonalcoholic Fatty liver disease: a pathogenic duo. Endocr Rev. 2013;34:84-129. [PMID: 23238855 DOI: 10.1210/er.2012-1009] [Cited by in Crossref: 132] [Cited by in F6Publishing: 127] [Article Influence: 13.2] [Reference Citation Analysis]
213 Farrell GC. The liver and the waistline: Fifty years of growth. J Gastroenterol Hepatol. 2009;24 Suppl 3:S105-S118. [PMID: 19799688 DOI: 10.1111/j.1440-1746.2009.06080.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 2.7] [Reference Citation Analysis]
214 Maher JJ. Pathogenesis of NAFLD and NASH. In: Chalasani N, Szabo G, editors. Alcoholic and Non-Alcoholic Fatty Liver Disease. Cham: Springer International Publishing; 2016. pp. 71-101. [DOI: 10.1007/978-3-319-20538-0_4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
215 Gao Z, Zhang J, Kheterpal I, Kennedy N, Davis RJ, Ye J. Sirtuin 1 (SIRT1) protein degradation in response to persistent c-Jun N-terminal kinase 1 (JNK1) activation contributes to hepatic steatosis in obesity. J Biol Chem. 2011;286:22227-22234. [PMID: 21540183 DOI: 10.1074/jbc.m111.228874] [Cited by in Crossref: 124] [Cited by in F6Publishing: 74] [Article Influence: 11.3] [Reference Citation Analysis]
216 Loria P, Lonardo A, Anania F. Liver and diabetes. A vicious circle. Hepatol Res 2013;43:51-64. [PMID: 23332087 DOI: 10.1111/j.1872-034X.2012.01031.x] [Cited by in Crossref: 114] [Cited by in F6Publishing: 66] [Article Influence: 12.7] [Reference Citation Analysis]
217 Wandrer F, Liebig S, Marhenke S, Vogel A, John K, Manns MP, Teufel A, Itzel T, Longerich T, Maier O, Fischer R, Kontermann RE, Pfizenmaier K, Schulze-Osthoff K, Bantel H. TNF-Receptor-1 inhibition reduces liver steatosis, hepatocellular injury and fibrosis in NAFLD mice. Cell Death Dis. 2020;11:212. [PMID: 32235829 DOI: 10.1038/s41419-020-2411-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
218 Anderson N, Borlak J. Molecular Mechanisms and Therapeutic Targets in Steatosis and Steatohepatitis. Pharmacol Rev 2008;60:311-57. [DOI: 10.1124/pr.108.00001] [Cited by in Crossref: 260] [Cited by in F6Publishing: 249] [Article Influence: 18.6] [Reference Citation Analysis]
219 Li T, Feng R, Zhao C, Wang Y, Wang J, Liu S, Cao J, Wang H, Wang T, Guo Y, Lu Z. Dimethylarginine Dimethylaminohydrolase 1 Protects Against High-Fat Diet-Induced Hepatic Steatosis and Insulin Resistance in Mice. Antioxidants & Redox Signaling 2017;26:598-609. [DOI: 10.1089/ars.2016.6742] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
220 Sommer J, Mahli A, Freese K, Schiergens TS, Kuecuekoktay FS, Teufel A, Thasler WE, Müller M, Bosserhoff AK, Hellerbrand C. Analysis of molecular mechanisms of 5-fluorouracil-induced steatosis and inflammation in vitro and in mice. Oncotarget 2017;8:13059-72. [PMID: 28055957 DOI: 10.18632/oncotarget.14371] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
221 Armutcu F, Akyol S, Ucar F, Erdogan S, Akyol O. Markers in Nonalcoholic Steatohepatitis. Elsevier; 2013. pp. 67-125. [DOI: 10.1016/b978-0-12-407680-8.00004-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
222 Wang X, Wu D, Yang L, Cederbaum AI. Hepatotoxicity mediated by pyrazole (cytochrome P450 2E1) plus tumor necrosis factor alpha treatment occurs in c-Jun N-terminal kinase 2-/- but not in c-Jun N-terminal kinase 1-/- mice. Hepatology 2011;54:1753-66. [PMID: 21748763 DOI: 10.1002/hep.24540] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
223 Nagarajan P, Mahesh Kumar MJ, Venkatesan R, Majundar SS, Juyal RC. Genetically modified mouse models for the study of nonalcoholic fatty liver disease. World J Gastroenterol 2012; 18(11): 1141-1153 [PMID: 22468076 DOI: 10.3748/wjg.v18.i11.1141] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 44] [Article Influence: 4.1] [Reference Citation Analysis]
224 Du J, Zhang M, Lu J, Zhang X, Xiong Q, Xu Y, Bao Y, Jia W. Osteocalcin improves nonalcoholic fatty liver disease in mice through activation of Nrf2 and inhibition of JNK. Endocrine 2016;53:701-9. [DOI: 10.1007/s12020-016-0926-5] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 7.0] [Reference Citation Analysis]
225 Jiang JX, Török NJ. MLK3 as a regulator of disease progression in Non-alcoholic steatohepatitis. Liver Int 2014;34:1131-2. [PMID: 24690035 DOI: 10.1111/liv.12556] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
226 Li L, Xia Y, Ji X, Wang H, Zhang Z, Lu P, Ding Q, Wang D, Liu M. MIG/CXCL9 exacerbates the progression of metabolic-associated fatty liver disease by disrupting Treg/Th17 balance. Exp Cell Res 2021;407:112801. [PMID: 34461107 DOI: 10.1016/j.yexcr.2021.112801] [Reference Citation Analysis]
227 Kaser S, Ebenbichler CF, Tilg H. Pharmacological and non-pharmacological treatment of non-alcoholic fatty liver disease: Treatment of NAFLD. International Journal of Clinical Practice 2010;64:968-83. [DOI: 10.1111/j.1742-1241.2009.02327.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
228 Baig MH, Baker A, Ashraf GM, Dong J. ASK1 and its role in cardiovascular and other disorders: available treatments and future prospects. Expert Review of Proteomics 2019;16:857-70. [DOI: 10.1080/14789450.2019.1676735] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
229 Kodama Y, Taura K, Miura K, Schnabl B, Osawa Y, Brenner DA. Antiapoptotic effect of c-Jun N-terminal Kinase-1 through Mcl-1 stabilization in TNF-induced hepatocyte apoptosis. Gastroenterology. 2009;136:1423-1434. [PMID: 19249395 DOI: 10.1053/j.gastro.2008.12.064] [Cited by in Crossref: 69] [Cited by in F6Publishing: 70] [Article Influence: 5.3] [Reference Citation Analysis]
230 Wang Y, Ausman LM, Russell RM, Greenberg AS, Wang XD. Increased apoptosis in high-fat diet-induced nonalcoholic steatohepatitis in rats is associated with c-Jun NH2-terminal kinase activation and elevated proapoptotic Bax. J Nutr. 2008;138:1866-1871. [PMID: 18806094 DOI: 10.1093/jn/138.10.1866] [Cited by in Crossref: 80] [Cited by in F6Publishing: 89] [Article Influence: 5.7] [Reference Citation Analysis]
231 Albracht-Schulte K, Gonzalez S, Jackson A, Wilson S, Ramalingam L, Kalupahana NS, Moustaid-Moussa N. Eicosapentaenoic Acid Improves Hepatic Metabolism and Reduces Inflammation Independent of Obesity in High-Fat-Fed Mice and in HepG2 Cells. Nutrients 2019;11:E599. [PMID: 30871035 DOI: 10.3390/nu11030599] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
232 Wang J, Tai G. Role of C-Jun N-terminal Kinase in Hepatocellular Carcinoma Development. Target Oncol 2016;11:723-38. [PMID: 27392951 DOI: 10.1007/s11523-016-0446-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
233 Srivastava S, Li Z, Yang X, Yedwabnick M, Shaw S, Chan C. Identification of genes that regulate multiple cellular processes/responses in the context of lipotoxicity to hepatoma cells. BMC Genomics 2007;8:364. [PMID: 17925029 DOI: 10.1186/1471-2164-8-364] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
234 Duwaerts CC, Maher JJ. Mechanisms of Liver Injury in Non-Alcoholic Steatohepatitis. Curr Hepatol Rep 2014;13:119-29. [PMID: 25045618 DOI: 10.1007/s11901-014-0224-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
235 Zhao G, Hatting M, Nevzorova YA, Peng J, Hu W, Boekschoten MV, Roskams T, Muller M, Gassler N, Liedtke C. Jnk1 in murine hepatic stellate cells is a crucial mediator of liver fibrogenesis. Gut. 2013;Epub ahead of print. [PMID: 24037431 DOI: 10.1136/gutjnl-2013-305507] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 3.7] [Reference Citation Analysis]
236 Mobasher MA, Valverde ÁM. Signalling pathways involved in paracetamol-induced hepatotoxicity: new insights on the role of protein tyrosine phosphatase 1B. Archives of Physiology and Biochemistry 2014;120:51-63. [DOI: 10.3109/13813455.2014.893365] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
237 Joshi-barve S, Barve SS, Amancherla K, Gobejishvili L, Hill D, Cave M, Hote P, Mcclain CJ. Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes. Hepatology 2007;46:823-30. [DOI: 10.1002/hep.21752] [Cited by in Crossref: 237] [Cited by in F6Publishing: 219] [Article Influence: 15.8] [Reference Citation Analysis]
238 Liu Y, Song H, Wang L, Xu H, Shu X, Zhang L, Li Y, Li D, Ji G. Hepatoprotective and antioxidant activities of extracts from Salvia-Nelumbinis naturalis against nonalcoholic steatohepatitis induced by methionine- and choline-deficient diet in mice. J Transl Med 2014;12:315. [PMID: 25406833 DOI: 10.1186/s12967-014-0315-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
239 Yuan S, Liu H, Yuan D, Xu J, Chen Y, Xu X, Xu F, Liang H. PNPLA3 I148M mediates the regulatory effect of NF-kB on inflammation in PA-treated HepG2 cells. J Cell Mol Med 2020;24:1541-52. [PMID: 31793207 DOI: 10.1111/jcmm.14839] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
240 Tsuzuki T, Shinozaki S, Nakamoto H, Kaneki M, Goto S, Shimokado K, Kobayashi H, Naito H. Voluntary Exercise Can Ameliorate Insulin Resistance by Reducing iNOS-Mediated S-Nitrosylation of Akt in the Liver in Obese Rats. PLoS One 2015;10:e0132029. [PMID: 26172834 DOI: 10.1371/journal.pone.0132029] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
241 Lu S, Natarajan SK, Mott JL, Kharbanda KK, Harrison-Findik DD. Ceramide Induces Human Hepcidin Gene Transcription through JAK/STAT3 Pathway. PLoS One 2016;11:e0147474. [PMID: 26807955 DOI: 10.1371/journal.pone.0147474] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
242 Garg R, Kumariya S, Katekar R, Verma S, Goand UK, Gayen JR. JNK signaling pathway in metabolic disorders: An emerging therapeutic target. Eur J Pharmacol 2021;901:174079. [PMID: 33812885 DOI: 10.1016/j.ejphar.2021.174079] [Reference Citation Analysis]
243 Czaja MJ. JNK regulation of hepatic manifestations of the metabolic syndrome. Trends Endocrinol Metab 2010;21:707-13. [PMID: 20888782 DOI: 10.1016/j.tem.2010.08.010] [Cited by in Crossref: 75] [Cited by in F6Publishing: 71] [Article Influence: 6.3] [Reference Citation Analysis]
244 Chen X, Li L, Liu X, Luo R, Liao G, Li L, Liu J, Cheng J, Lu Y, Chen Y. Oleic acid protects saturated fatty acid mediated lipotoxicity in hepatocytes and rat of non-alcoholic steatohepatitis. Life Sciences 2018;203:291-304. [DOI: 10.1016/j.lfs.2018.04.022] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 11.8] [Reference Citation Analysis]
245 Farrell GC, Larter CZ, Hou JY, Zhang RH, Yeh MM, Williams J, dela Pena A, Francisco R, Osvath SR, Brooling J. Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression. J Gastroenterol Hepatol. 2009;24:443-452. [PMID: 19226377 DOI: 10.1111/j.1440-1746.2009.05785.x] [Cited by in Crossref: 87] [Cited by in F6Publishing: 83] [Article Influence: 6.2] [Reference Citation Analysis]
246 Liu Q, Bengmark S, Qu S. The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD). Lipids Health Dis. 2010;9:42. [PMID: 20426802 DOI: 10.1186/1476-511x-9-42] [Cited by in Crossref: 108] [Cited by in F6Publishing: 54] [Article Influence: 9.0] [Reference Citation Analysis]
247 Schattenberg JM, Czaja MJ. Regulation of the effects of CYP2E1-induced oxidative stress by JNK signaling. Redox Biol 2014;3:7-15. [PMID: 25462060 DOI: 10.1016/j.redox.2014.09.004] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 4.9] [Reference Citation Analysis]
248 Tsedensodnom O, Sadler KC. ROS: redux and paradox in fatty liver disease. Hepatology 2013;58:1210-2. [PMID: 23703804 DOI: 10.1002/hep.26497] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
249 Wang Y, Singh R, Xiang Y, Czaja MJ. Macroautophagy and chaperone-mediated autophagy are required for hepatocyte resistance to oxidant stress. Hepatology. 2010;52:266-277. [PMID: 20578144 DOI: 10.1002/hep.23645] [Cited by in Crossref: 84] [Cited by in F6Publishing: 82] [Article Influence: 7.0] [Reference Citation Analysis]
250 Yeh MM, Belt P, Brunt EM, Kowdley KV, Wilson LA, Ferrell L; Nonalcoholic Steatohepatitis Clinical Research Network. Acidophil bodies in nonalcoholic steatohepatitis. Hum Pathol 2016;52:28-37. [PMID: 26980020 DOI: 10.1016/j.humpath.2016.01.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
251 Sun B, Karin M. Obesity, inflammation, and liver cancer. J Hepatol. 2012;56:704-713. [PMID: 22120206 DOI: 10.1016/j.jhep.2011.09.020] [Cited by in Crossref: 284] [Cited by in F6Publishing: 267] [Article Influence: 25.8] [Reference Citation Analysis]
252 Guo C, Xue H, Guo T, Zhang W, Xuan WQ, Ren YT, Wang D, Chen YH, Meng YH, Gao HL, Zhao P. Recombinant human lactoferrin attenuates the progression of hepatosteatosis and hepatocellular death by regulating iron and lipid homeostasis in ob/ob mice. Food Funct 2020;11:7183-96. [PMID: 32756704 DOI: 10.1039/d0fo00910e] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
253 Luyendyk JP, Sullivan BP, Guo GL, Wang R. Tissue factor-deficiency and protease activated receptor-1-deficiency reduce inflammation elicited by diet-induced steatohepatitis in mice. Am J Pathol 2010;176:177-86. [PMID: 20008134 DOI: 10.2353/ajpath.2010.090672] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 2.8] [Reference Citation Analysis]
254 Gautheron J, Vucur M, Reisinger F, Cardenas DV, Roderburg C, Koppe C, Kreggenwinkel K, Schneider AT, Bartneck M, Neumann UP. A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis. EMBO Mol Med. 2014;6:1062-1074. [PMID: 24963148 DOI: 10.15252/emmm.201403856] [Cited by in Crossref: 163] [Cited by in F6Publishing: 156] [Article Influence: 23.3] [Reference Citation Analysis]
255 Gentile CL, Frye MA, Pagliassotti MJ. Fatty acids and the endoplasmic reticulum in nonalcoholic fatty liver disease. Biofactors 2011;37:8-16. [PMID: 21328622 DOI: 10.1002/biof.135] [Cited by in Crossref: 97] [Cited by in F6Publishing: 64] [Article Influence: 8.1] [Reference Citation Analysis]
256 Engin A. Human Protein Kinases and Obesity. In: Engin AB, Engin A, editors. Obesity and Lipotoxicity. Cham: Springer International Publishing; 2017. pp. 111-34. [DOI: 10.1007/978-3-319-48382-5_5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
257 Schuppan D, Schattenberg JM. Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches. J Gastroenterol Hepatol. 2013;28 Suppl 1:68-76. [PMID: 23855299 DOI: 10.1111/jgh.12212] [Cited by in Crossref: 148] [Cited by in F6Publishing: 145] [Article Influence: 18.5] [Reference Citation Analysis]
258 Takahashi Y, Soejima Y, Fukusato T. Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J Gastroenterol 2012; 18(19): 2300-2308 [PMID: 22654421 DOI: 10.3748/wjg.v18.i19.2300] [Cited by in CrossRef: 331] [Cited by in F6Publishing: 315] [Article Influence: 33.1] [Reference Citation Analysis]
259 Roberts EA. Pediatric nonalcoholic fatty liver disease (NAFLD): A “growing” problem? Journal of Hepatology 2007;46:1133-42. [DOI: 10.1016/j.jhep.2007.03.003] [Cited by in Crossref: 123] [Cited by in F6Publishing: 102] [Article Influence: 8.2] [Reference Citation Analysis]
260 Marra F, Lotersztajn S. Pathophysiology of NASH: perspectives for a targeted treatment. Curr Pharm Des 2013;19:5250-69. [PMID: 23394092 DOI: 10.2174/13816128113199990344] [Cited by in Crossref: 94] [Cited by in F6Publishing: 96] [Article Influence: 11.8] [Reference Citation Analysis]
261 Park E, Giacca A. Mechanisms underlying fat-induced hepatic insulin resistance. Future Lipidology 2007;2:503-12. [DOI: 10.2217/17460875.2.5.503] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
262 Gehrke N, Schattenberg JM. Metabolic Inflammation—A Role for Hepatic Inflammatory Pathways as Drivers of Comorbidities in Nonalcoholic Fatty Liver Disease? Gastroenterology 2020;158:1929-1947.e6. [DOI: 10.1053/j.gastro.2020.02.020] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 22.5] [Reference Citation Analysis]
263 Aouadi M, Binetruy B, Caron L, Le Marchand-Brustel Y, Bost F. Role of MAPKs in development and differentiation: lessons from knockout mice. Biochimie. 2006;88:1091-1098. [PMID: 16854512 DOI: 10.1016/j.biochi.2006.06.003] [Cited by in Crossref: 102] [Cited by in F6Publishing: 109] [Article Influence: 6.4] [Reference Citation Analysis]
264 Park SH. [Nonalcoholic steatohepatitis: pathogenesis and treatment]. Korean J Hepatol 2008;14:12-27. [PMID: 18367854 DOI: 10.3350/kjhep.2008.14.1.12] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
265 Takamura M, Matsuda Y, Yamagiwa S, Tamura Y, Honda Y, Suzuki K, Ichida T, Aoyagi Y. An inhibitor of c-Jun NH2-terminal kinase, SP600125, protects mice from D-galactosamine/lipopolysaccharide-induced hepatic failure by modulating BH3-only proteins. Life Sci. 2007;80:1335-1344. [PMID: 17300814 DOI: 10.1016/j.lfs.2006.12.034] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 2.5] [Reference Citation Analysis]
266 Shimizu M, Tanaka T, Moriwaki H. Obesity and hepatocellular carcinoma: targeting obesity-related inflammation for chemoprevention of liver carcinogenesis. Semin Immunopathol. 2013;35:191-202. [PMID: 22945457 DOI: 10.1007/s00281-012-0336-6] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 3.6] [Reference Citation Analysis]
267 Jia R, Cao LP, Du JL, He Q, Gu ZY, Jeney G, Xu P, Yin GJ. Effects of high-fat diet on antioxidative status, apoptosis and inflammation in liver of tilapia (Oreochromis niloticus) via Nrf2, TLRs and JNK pathways. Fish Shellfish Immunol 2020;104:391-401. [PMID: 32553566 DOI: 10.1016/j.fsi.2020.06.025] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
268 Arfianti A, Pok S, Barn V, Haigh WG, Yeh MM, Ioannou GN, Teoh NC, Farrell GC. Exercise retards hepatocarcinogenesis in obese mice independently of weight control. J Hepatol 2020;73:140-8. [PMID: 32302728 DOI: 10.1016/j.jhep.2020.02.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
269 Jiang CM, Pu CW, Hou YH, Chen Z, Alanazy M, Hebbard L. Non alcoholic steatohepatitis a precursor for hepatocellular carcinoma development. World J Gastroenterol 2014; 20(44): 16464-16473 [PMID: 25469014 DOI: 10.3748/wjg.v20.i44.16464] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.8] [Reference Citation Analysis]
270 Cubero FJ, Drvarov O, Trautwein C, Kowdley K, Mccaughan G, Trautwein C. c-Jun NH2-terminal kinase 1 in hepatocytes: An essential mediator of insulin resistance. Hepatology 2010;51:2221-3. [DOI: 10.1002/hep.23737] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
271 Zhang Y, Zhou G, Chen Z, Guan W, Zhang J, Bi M, Wang F, You X, Liao Y, Zheng S, Xu K, Yang H. Si-Wu-Tang Alleviates Nonalcoholic Fatty Liver Disease via Blocking TLR4-JNK and Caspase-8-GSDMD Signaling Pathways. Evid Based Complement Alternat Med 2020;2020:8786424. [PMID: 32849904 DOI: 10.1155/2020/8786424] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
272 Mahli A, Koch A, Fresse K, Schiergens T, Thasler WE, Schönberger C, Bergheim I, Bosserhoff A, Hellerbrand C. Iso-alpha acids from hops (Humulus lupulus) inhibit hepatic steatosis, inflammation, and fibrosis. Lab Invest 2018;98:1614-26. [PMID: 30089858 DOI: 10.1038/s41374-018-0112-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
273 Flach RJ, Qin H, Zhang L, Bennett AM. Loss of mitogen-activated protein kinase phosphatase-1 protects from hepatic steatosis by repression of cell death-inducing DNA fragmentation factor A (DFFA)-like effector C (CIDEC)/fat-specific protein 27. J Biol Chem 2011;286:22195-202. [PMID: 21521693 DOI: 10.1074/jbc.M110.210237] [Cited by in Crossref: 36] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
274 Gonçalves I, Martins M, Beleza J, Ascensão A, Magalhães J. Exercise, Liver Steatosis, and Free Radicals. Liver Pathophysiology. Elsevier; 2017. pp. 309-22. [DOI: 10.1016/b978-0-12-804274-8.00024-2] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
275 Wu D, Cederbaum AI. Inhibition of autophagy promotes CYP2E1-dependent toxicity in HepG2 cells via elevated oxidative stress, mitochondria dysfunction and activation of p38 and JNK MAPK. Redox Biol. 2013;1:552-565. [PMID: 24273738 DOI: 10.1016/j.redox.2013.10.008] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 5.7] [Reference Citation Analysis]
276 Tarantino G, Caputi A. JNKs, insulin resistance and inflammation: A possible link between NAFLD and coronary artery disease. World J Gastroenterol 2011; 17(33): 3785-3794 [PMID: 21987620 DOI: 10.3748/wjg.v17.i33.3785] [Cited by in CrossRef: 82] [Cited by in F6Publishing: 80] [Article Influence: 7.5] [Reference Citation Analysis]
277 Kovalic AJ, Satapathy SK, Chalasani N. Targeting incretin hormones and the ASK-1 pathway as therapeutic options in the treatment of non-alcoholic steatohepatitis. Hepatol Int. 2018;12:97-106. [PMID: 29600430 DOI: 10.1007/s12072-018-9854-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
278 Xie, Zhao H, Lu J, He F, Liu W, Yu W, Wang Q, Hisatome I, Yamamoto T, Koyama H, Cheng J. High uric acid induces liver fat accumulation via ROS/JNK/AP-1 signaling. Am J Physiol Endocrinol Metab 2021;320:E1032-43. [PMID: 33900847 DOI: 10.1152/ajpendo.00518.2020] [Reference Citation Analysis]
279 Sanhueza S, Tobar N, Cifuentes M, Quenti D, Varì R, Scazzocchio B, Masella R, Herrera K, Paredes A, Morales G, Ormazabal P. Lampaya Medicinalis Phil. decreases lipid-induced triglyceride accumulation and proinflammatory markers in human hepatocytes and fat body of Drosophila melanogaster. Int J Obes (Lond) 2021;45:1464-75. [PMID: 33895783 DOI: 10.1038/s41366-021-00811-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
280 Olivares S, Green RM, Henkel AS. Endoplasmic reticulum stress activates the hepatic activator protein 1 complex via mitogen activated protein kinase-dependent signaling pathways. PLoS One 2014;9:e103828. [PMID: 25077945 DOI: 10.1371/journal.pone.0103828] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
281 Buzzetti E, Pinzani M, Tsochatzis EA. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism. 2016;65:1038-1048. [PMID: 26823198 DOI: 10.1016/j.metabol.2015.12.012] [Cited by in Crossref: 901] [Cited by in F6Publishing: 867] [Article Influence: 150.2] [Reference Citation Analysis]
282 Shen B, Yu J, Wang S, Chu ES, Wong VW, Zhou X, Lin G, Sung JJ, Chan HL. Phyllanthus urinaria ameliorates the severity of nutritional steatohepatitis both in vitro and in vivo. Hepatology 2008;47:473-83. [PMID: 18157836 DOI: 10.1002/hep.22039] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
283 Trauner M, Arrese M, Wagner M. Fatty liver and lipotoxicity. Biochim Biophys Acta. 2010;1801:299-310. [PMID: 19857603 DOI: 10.1016/j.bbalip.2009.10.007] [Cited by in Crossref: 178] [Cited by in F6Publishing: 186] [Article Influence: 13.7] [Reference Citation Analysis]
284 Zhang L, Yang M, Ren H, Hu H, Boden G, Li L, Yang G. GLP-1 analogue prevents NAFLD in ApoE KO mice with diet and Acrp30 knockdown by inhibiting c-JNK. Liver Int. 2013;33:794-804. [PMID: 23432843 DOI: 10.1111/liv.12120] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 4.3] [Reference Citation Analysis]
285 Kim SM, Grenert JP, Patterson C, Correia MA. CHIP(-/-)-Mouse Liver: Adiponectin-AMPK-FOXO-Activation Overrides CYP2E1-Elicited JNK1-Activation, Delaying Onset of NASH: Therapeutic Implications. Sci Rep 2016;6:29423. [PMID: 27406999 DOI: 10.1038/srep29423] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]